CA2584248A1 - Procede pour traiter des lesions vasculaires - Google Patents
Procede pour traiter des lesions vasculaires Download PDFInfo
- Publication number
- CA2584248A1 CA2584248A1 CA002584248A CA2584248A CA2584248A1 CA 2584248 A1 CA2584248 A1 CA 2584248A1 CA 002584248 A CA002584248 A CA 002584248A CA 2584248 A CA2584248 A CA 2584248A CA 2584248 A1 CA2584248 A1 CA 2584248A1
- Authority
- CA
- Canada
- Prior art keywords
- pyridin
- methyl
- imidazol
- benzo
- dioxol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 51
- 208000024248 Vascular System injury Diseases 0.000 title description 5
- 208000012339 Vascular injury Diseases 0.000 title description 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 83
- 208000032594 Vascular Remodeling Diseases 0.000 claims abstract description 27
- 206010020772 Hypertension Diseases 0.000 claims abstract description 26
- 206010072810 Vascular wall hypertrophy Diseases 0.000 claims abstract description 20
- 208000037803 restenosis Diseases 0.000 claims abstract description 16
- 210000000056 organ Anatomy 0.000 claims abstract description 11
- 208000019553 vascular disease Diseases 0.000 claims abstract description 9
- 230000002093 peripheral effect Effects 0.000 claims abstract description 7
- 208000002815 pulmonary hypertension Diseases 0.000 claims abstract description 4
- 206010042957 Systolic hypertension Diseases 0.000 claims abstract description 3
- 208000007530 Essential hypertension Diseases 0.000 claims abstract 2
- 201000004239 Secondary hypertension Diseases 0.000 claims abstract 2
- 125000000217 alkyl group Chemical group 0.000 claims description 336
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 321
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 270
- -1 hydroxy, amino, nitro, oxo, thioxo Chemical group 0.000 claims description 269
- 125000001072 heteroaryl group Chemical group 0.000 claims description 231
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 211
- 125000003118 aryl group Chemical group 0.000 claims description 161
- 125000003545 alkoxy group Chemical group 0.000 claims description 149
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 149
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 147
- 125000004414 alkyl thio group Chemical group 0.000 claims description 125
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 claims description 122
- 125000003342 alkenyl group Chemical group 0.000 claims description 118
- 125000000304 alkynyl group Chemical group 0.000 claims description 103
- 125000002252 acyl group Chemical group 0.000 claims description 95
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 89
- 125000004104 aryloxy group Chemical group 0.000 claims description 86
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 86
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 83
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 83
- 125000000000 cycloalkoxy group Chemical group 0.000 claims description 82
- 125000005843 halogen group Chemical group 0.000 claims description 80
- 125000004475 heteroaralkyl group Chemical group 0.000 claims description 79
- 229910052739 hydrogen Inorganic materials 0.000 claims description 78
- 239000001257 hydrogen Substances 0.000 claims description 78
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 77
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 76
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 75
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 claims description 75
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 claims description 74
- 125000003435 aroyl group Chemical group 0.000 claims description 72
- 150000002431 hydrogen Chemical class 0.000 claims description 71
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 68
- 239000004202 carbamide Substances 0.000 claims description 68
- 125000005163 aryl sulfanyl group Chemical group 0.000 claims description 65
- 125000005171 cycloalkylsulfanyl group Chemical group 0.000 claims description 65
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 65
- 125000005224 heteroarylcarbonylamino group Chemical group 0.000 claims description 54
- 125000004658 aryl carbonyl amino group Chemical group 0.000 claims description 53
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 49
- 125000004122 cyclic group Chemical group 0.000 claims description 47
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims description 47
- 239000003112 inhibitor Substances 0.000 claims description 43
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 claims description 35
- 125000005419 heteroarylsulfonylamino group Chemical group 0.000 claims description 35
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 34
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 claims description 33
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 30
- 125000005126 aryl alkyl carbonyl amino group Chemical group 0.000 claims description 29
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 29
- 125000005169 cycloalkylcarbonylamino group Chemical group 0.000 claims description 28
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 28
- 229910052757 nitrogen Inorganic materials 0.000 claims description 25
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 24
- 150000001204 N-oxides Chemical class 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 23
- 125000005018 aryl alkenyl group Chemical group 0.000 claims description 20
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 19
- 125000001188 haloalkyl group Chemical group 0.000 claims description 18
- 125000005114 heteroarylalkoxy group Chemical group 0.000 claims description 15
- 125000004043 oxo group Chemical group O=* 0.000 claims description 13
- 125000000623 heterocyclic group Chemical group 0.000 claims description 11
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims description 11
- SARWAMFCNRRZTD-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-piperidin-4-yl-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCNCC2)C=2C=C3OCOC3=CC=2)=N1 SARWAMFCNRRZTD-UHFFFAOYSA-N 0.000 claims description 10
- MQZAFVXXIGNUPG-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)pyrazolo[1,5-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C=2C(=C3C=CC=CN3N=2)C=2N=C(N)N=CC=2)=N1 MQZAFVXXIGNUPG-UHFFFAOYSA-N 0.000 claims description 10
- 125000004450 alkenylene group Chemical group 0.000 claims description 10
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 10
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- 125000004419 alkynylene group Chemical group 0.000 claims description 10
- 150000001408 amides Chemical class 0.000 claims description 10
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims description 10
- 125000005015 aryl alkynyl group Chemical group 0.000 claims description 10
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims description 10
- VYMTWHZMUYWTDG-UHFFFAOYSA-N benzyl 3-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CN(CCC2)C(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 VYMTWHZMUYWTDG-UHFFFAOYSA-N 0.000 claims description 10
- HJTDQRHNNVDYNJ-UHFFFAOYSA-N benzyl 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1C(=O)OCC1=CC=CC=C1 HJTDQRHNNVDYNJ-UHFFFAOYSA-N 0.000 claims description 10
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 10
- 125000005149 cycloalkylsulfinyl group Chemical group 0.000 claims description 10
- 125000005150 heteroarylsulfinyl group Chemical group 0.000 claims description 10
- OOBORGGKBQGOQB-UHFFFAOYSA-N n-[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]acetamide Chemical compound CC(=O)NC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 OOBORGGKBQGOQB-UHFFFAOYSA-N 0.000 claims description 10
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims description 10
- QQXSDZAMXCQBPE-UHFFFAOYSA-N benzyl 3-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]pyrrolidine-1-carboxylate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CN(CC2)C(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 QQXSDZAMXCQBPE-UHFFFAOYSA-N 0.000 claims description 9
- KOJILNLSRNSDPE-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(O)=O)C=2C=C3OCOC3=CC=2)=N1 KOJILNLSRNSDPE-UHFFFAOYSA-N 0.000 claims description 8
- KLLKKKAXFTYAGU-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxylic acid Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C(O)=O)C=2N=C(N)N=CC=2)=N1 KLLKKKAXFTYAGU-UHFFFAOYSA-N 0.000 claims description 8
- QAALUNOPVWULBE-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxylic acid Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(O)=O)C=2N=C(N)N=CC=2)=N1 QAALUNOPVWULBE-UHFFFAOYSA-N 0.000 claims description 7
- YURRESDVZOTIIE-UHFFFAOYSA-N 1-[5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(O)=O)C2=CN3N=CN=C3C=C2)=N1 YURRESDVZOTIIE-UHFFFAOYSA-N 0.000 claims description 6
- 101001053401 Arabidopsis thaliana Acid beta-fructofuranosidase 3, vacuolar Proteins 0.000 claims description 6
- 101001053395 Arabidopsis thaliana Acid beta-fructofuranosidase 4, vacuolar Proteins 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000006574 non-aromatic ring group Chemical group 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- TWFAJNXORPXXHJ-UHFFFAOYSA-N (2-chlorophenyl)methyl 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound ClC1=CC=CC=C1COC(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 TWFAJNXORPXXHJ-UHFFFAOYSA-N 0.000 claims description 5
- XPHBQOUOAVUTLL-UHFFFAOYSA-N (4,5-dimethoxy-2-nitrophenyl)methyl 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound C1=C(OC)C(OC)=CC(COC(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)=C1[N+]([O-])=O XPHBQOUOAVUTLL-UHFFFAOYSA-N 0.000 claims description 5
- JBVFHFGCUCLBAC-UHFFFAOYSA-N (4-nitrophenyl)methyl 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 JBVFHFGCUCLBAC-UHFFFAOYSA-N 0.000 claims description 5
- BDCDBMMOQZVEQQ-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-cyclopropylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound C1CC(C(=O)O)(CC2)CCC12C(NC=1C=2C=C3OCOC3=CC=2)=NC=1C(N=1)=CC=CC=1C1CC1 BDCDBMMOQZVEQQ-UHFFFAOYSA-N 0.000 claims description 5
- PSFNVZCUNRDLSM-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n,n-diethylbicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)N(CC)CC)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 PSFNVZCUNRDLSM-UHFFFAOYSA-N 0.000 claims description 5
- TYKPSDLNBWREBQ-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n,n-dimethylbicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)N(C)C)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 TYKPSDLNBWREBQ-UHFFFAOYSA-N 0.000 claims description 5
- AVBSRIGBTOAPCC-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n,n-dipropylbicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)N(CCC)CCC)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 AVBSRIGBTOAPCC-UHFFFAOYSA-N 0.000 claims description 5
- SCLUKIYIEQXKPC-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(1,3-benzothiazol-2-yl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NC=2SC3=CC=CC=C3N=2)C=2C=C3OCOC3=CC=2)=N1 SCLUKIYIEQXKPC-UHFFFAOYSA-N 0.000 claims description 5
- WQGFGKHYEZFVEL-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(1-hydroxy-1-phenylpropan-2-yl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound C=1C=CC=CC=1C(O)C(C)NC(=O)C(CC1)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 WQGFGKHYEZFVEL-UHFFFAOYSA-N 0.000 claims description 5
- OYLSBWOMVFQWKV-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(1-methyl-5-methylsulfanyl-1,2,4-triazol-3-yl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound CN1C(SC)=NC(NC(=O)C23CCC(CC2)(CC3)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=C(C)C=CC=2)=N1 OYLSBWOMVFQWKV-UHFFFAOYSA-N 0.000 claims description 5
- YKNSIFNFRJZJNZ-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(5,7-difluoro-1,3-benzothiazol-2-yl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NC=2SC3=C(F)C=C(F)C=C3N=2)C=2C=C3OCOC3=CC=2)=N1 YKNSIFNFRJZJNZ-UHFFFAOYSA-N 0.000 claims description 5
- ZNHHQIKDYUGVDY-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(pyridin-2-ylmethyl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NCC=2N=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 ZNHHQIKDYUGVDY-UHFFFAOYSA-N 0.000 claims description 5
- IDMSXJAGKSMKAQ-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(pyridin-4-ylmethyl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NCC=2C=CN=CC=2)C=2C=C3OCOC3=CC=2)=N1 IDMSXJAGKSMKAQ-UHFFFAOYSA-N 0.000 claims description 5
- ZUTIQUZCDSCVSY-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-benzylbicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 ZUTIQUZCDSCVSY-UHFFFAOYSA-N 0.000 claims description 5
- OLKOQFCACIBBJG-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-hydroxybicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(=O)NO)C=2C=C3OCOC3=CC=2)=N1 OLKOQFCACIBBJG-UHFFFAOYSA-N 0.000 claims description 5
- RFHKQZKAHKOHRP-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-methoxybicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)NOC)(CC2)CCC12C(NC=1C=2C=C3OCOC3=CC=2)=NC=1C1=CC=CC(C)=N1 RFHKQZKAHKOHRP-UHFFFAOYSA-N 0.000 claims description 5
- SCJDMLODCHYEER-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-methylsulfonylbicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NS(C)(=O)=O)C=2C=C3OCOC3=CC=2)=N1 SCJDMLODCHYEER-UHFFFAOYSA-N 0.000 claims description 5
- DKSAUIAQFZUDED-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octan-4-amine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(N)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 DKSAUIAQFZUDED-UHFFFAOYSA-N 0.000 claims description 5
- XDONAADVYDVOCU-UHFFFAOYSA-N 1-[4-(3-methyl-4-oxoquinazolin-6-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(O)=O)C=2C=C3C(=O)N(C)C=NC3=CC=2)=N1 XDONAADVYDVOCU-UHFFFAOYSA-N 0.000 claims description 5
- KXENDECZPMIZLE-UHFFFAOYSA-N 1-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidin-1-yl]-3-phenylpropan-1-one Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)CCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 KXENDECZPMIZLE-UHFFFAOYSA-N 0.000 claims description 5
- SPIRDUBGWMKCEE-UHFFFAOYSA-N 1-[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 SPIRDUBGWMKCEE-UHFFFAOYSA-N 0.000 claims description 5
- QNTZUABGHJBFPJ-UHFFFAOYSA-N 1-[4-[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]sulfonylphenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1S(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 QNTZUABGHJBFPJ-UHFFFAOYSA-N 0.000 claims description 5
- REYSLEGAAKFCRQ-UHFFFAOYSA-N 1-[5-(2-aminopyrimidin-4-yl)-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(O)=O)C=2N=C(N)N=CC=2)=N1 REYSLEGAAKFCRQ-UHFFFAOYSA-N 0.000 claims description 5
- DCSXVNBJFYIXIH-UHFFFAOYSA-N 1-[5-(2-methylpyrimidin-4-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=NC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(N)=O)C2=CN3N=CN=C3C=C2)=N1 DCSXVNBJFYIXIH-UHFFFAOYSA-N 0.000 claims description 5
- GDAIFEPYRASGRM-UHFFFAOYSA-N 1-[5-(2-methylpyrimidin-4-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound CC1=NC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(O)=O)C2=CN3N=CN=C3C=C2)=N1 GDAIFEPYRASGRM-UHFFFAOYSA-N 0.000 claims description 5
- KIZAXJYFDWLRFS-UHFFFAOYSA-N 1-[5-(2-methylpyrimidin-4-yl)-4-([1,2,4]triazolo[4,3-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octan-4-ol Chemical compound CC1=NC=CC(C2=C(N=C(N2)C23CCC(O)(CC2)CC3)C2=CN3C=NN=C3C=C2)=N1 KIZAXJYFDWLRFS-UHFFFAOYSA-N 0.000 claims description 5
- SQYJKVGOSYWORT-UHFFFAOYSA-N 1-[5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2,3-dihydroindol-1-yl]ethanone Chemical compound C=1C=C2N(C(=O)C)CCC2=CC=1C1=CNN=C1C1=CC=CC=N1 SQYJKVGOSYWORT-UHFFFAOYSA-N 0.000 claims description 5
- YGHSVVBPXIXHSF-UHFFFAOYSA-N 1-[5-(6-cyclopropylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]-n-hydroxybicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)NO)(CC2)CCC12C(NC=1C2=CN3N=CN=C3C=C2)=NC=1C(N=1)=CC=CC=1C1CC1 YGHSVVBPXIXHSF-UHFFFAOYSA-N 0.000 claims description 5
- NVJLNUFBDYBWQY-UHFFFAOYSA-N 1-[5-(6-cyclopropylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound C1CC(C(=O)O)(CC2)CCC12C(NC=1C2=CN3N=CN=C3C=C2)=NC=1C(N=1)=CC=CC=1C1CC1 NVJLNUFBDYBWQY-UHFFFAOYSA-N 0.000 claims description 5
- YIBGSDUTNZLXET-UHFFFAOYSA-N 1-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(O)=O)C=2C=C3N=CC=NC3=CC=2)=N1 YIBGSDUTNZLXET-UHFFFAOYSA-N 0.000 claims description 5
- GWJQEWCTGGIYQC-UHFFFAOYSA-N 1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylic acid Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(O)=O)C=2N=C(NC3CC3)N=CC=2)=N1 GWJQEWCTGGIYQC-UHFFFAOYSA-N 0.000 claims description 5
- PLFVJNCDYWCWML-UHFFFAOYSA-N 1-[6-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]pyridin-2-yl]ethanol Chemical compound CC(O)C1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 PLFVJNCDYWCWML-UHFFFAOYSA-N 0.000 claims description 5
- XYMWHITVFQOZSE-UHFFFAOYSA-N 1-methoxy-4-(5-pyridin-2-yl-1h-pyrazol-4-yl)isoquinoline Chemical compound C12=CC=CC=C2C(OC)=NC=C1C1=CNN=C1C1=CC=CC=N1 XYMWHITVFQOZSE-UHFFFAOYSA-N 0.000 claims description 5
- SFZYRCUDHYKJJC-UHFFFAOYSA-N 1-tert-butyl-3-[6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-yl]urea Chemical compound C1=C2C(NC(=O)NC(C)(C)C)=NC=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 SFZYRCUDHYKJJC-UHFFFAOYSA-N 0.000 claims description 5
- LRKYHEWFSVQJMQ-UHFFFAOYSA-N 2,3-dimethyl-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-one Chemical compound C1=C2C(=O)N(C)C(C)=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 LRKYHEWFSVQJMQ-UHFFFAOYSA-N 0.000 claims description 5
- MFNRPQVYVRQKII-UHFFFAOYSA-N 2,4-dimethoxy-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)pyrimidine Chemical compound COC1=NC(OC)=NC=C1C1=C(C=2N=CC=CC=2)NN=C1 MFNRPQVYVRQKII-UHFFFAOYSA-N 0.000 claims description 5
- QFVDOHIBLYRLPY-UHFFFAOYSA-N 2-(2,7-difluoro-3-hydroxy-6-oxoxanthen-9-yl)-5-[4-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]butylcarbamoyl]benzoic acid Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCCNC(=O)C=3C=C(C(=CC=3)C3=C4C=C(F)C(=O)C=C4OC4=CC(O)=C(F)C=C43)C(O)=O)N=CC=2)=N1 QFVDOHIBLYRLPY-UHFFFAOYSA-N 0.000 claims description 5
- MCMKSMNPHIBOLT-UHFFFAOYSA-N 2-(3-methoxyphenyl)-n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]acetamide Chemical compound COC1=CC=CC(CC(=O)NC2=NC3=NC(=C(N3C=C2)C=2N=C(N=CC=2)S(C)(=O)=O)C=2N=C(C)C=CC=2)=C1 MCMKSMNPHIBOLT-UHFFFAOYSA-N 0.000 claims description 5
- BUVRVVBYIQDIDT-UHFFFAOYSA-N 2-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)ethanamine Chemical compound N=1N(CCN)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 BUVRVVBYIQDIDT-UHFFFAOYSA-N 0.000 claims description 5
- FLMHPOCIZIPARJ-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CSC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 FLMHPOCIZIPARJ-UHFFFAOYSA-N 0.000 claims description 5
- VYFQAELHCIQANB-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-amine Chemical compound CSC1=NC=CC(C=2N3C=CC(N)=NC3=NC=2C=2N=C(C)C=CC=2)=N1 VYFQAELHCIQANB-UHFFFAOYSA-N 0.000 claims description 5
- DRUPRNRFTAHFGT-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 DRUPRNRFTAHFGT-UHFFFAOYSA-N 0.000 claims description 5
- DOGVCZGYQZYXAP-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridine-6-carbonitrile Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C#N)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 DOGVCZGYQZYXAP-UHFFFAOYSA-N 0.000 claims description 5
- QBVDQHQMPZYGCP-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2-piperidin-1-ylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N=CC=2)N2CCCCC2)=N1 QBVDQHQMPZYGCP-UHFFFAOYSA-N 0.000 claims description 5
- IYTJQGUUWQZKMH-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-[2-(2h-tetrazol-5-yl)pyrimidin-4-yl]imidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N=CC=2)C=2NN=NN=2)=N1 IYTJQGUUWQZKMH-UHFFFAOYSA-N 0.000 claims description 5
- WVAVXRCQIICYRN-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-pyrimidin-4-ylimidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=CN=CC=2)=N1 WVAVXRCQIICYRN-UHFFFAOYSA-N 0.000 claims description 5
- TVCVBBJSTVIFLY-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-pyrimidin-4-ylimidazo[1,2-a]pyrimidin-7-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC(N)=NC3=N2)C=2N=CN=CC=2)=N1 TVCVBBJSTVIFLY-UHFFFAOYSA-N 0.000 claims description 5
- AEUAOIYYRAMAQD-UHFFFAOYSA-N 2-[2-(1-benzylsulfonylpiperidin-4-yl)-4-(2-fluoropyridin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=CC=CC=2)C=2C=C(F)N=CC=2)=N1 AEUAOIYYRAMAQD-UHFFFAOYSA-N 0.000 claims description 5
- ISXNRDZPHJMGIT-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 ISXNRDZPHJMGIT-UHFFFAOYSA-N 0.000 claims description 5
- WPTMLMRCXDJZNI-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-6-cyclopropylpyridine Chemical compound C1CC1C1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 WPTMLMRCXDJZNI-UHFFFAOYSA-N 0.000 claims description 5
- VQNGFTSKHNQZEI-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-6-ethenylpyridine Chemical compound C=CC1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 VQNGFTSKHNQZEI-UHFFFAOYSA-N 0.000 claims description 5
- BJYFDVHHZLGZSW-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-6-ethylpyridine Chemical compound CCC1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 BJYFDVHHZLGZSW-UHFFFAOYSA-N 0.000 claims description 5
- XPJQTAGLWLONLB-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-6-prop-1-enylpyridine Chemical compound CC=CC1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 XPJQTAGLWLONLB-UHFFFAOYSA-N 0.000 claims description 5
- VZQJKFWHVVOZGS-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-6-propan-2-ylpyridine Chemical compound CC(C)C1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 VZQJKFWHVVOZGS-UHFFFAOYSA-N 0.000 claims description 5
- DDLCKXIXNHICNI-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-6-propylpyridine Chemical compound CCCC1=CC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 DDLCKXIXNHICNI-UHFFFAOYSA-N 0.000 claims description 5
- YHDUMDBRUMICHF-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-benzylsulfonylpiperidin-3-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CN(CCC2)S(=O)(=O)CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 YHDUMDBRUMICHF-UHFFFAOYSA-N 0.000 claims description 5
- KFRZBSUJGFDECR-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-benzylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-bromopyridine Chemical compound BrC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 KFRZBSUJGFDECR-UHFFFAOYSA-N 0.000 claims description 5
- YUOCFEKWIWPITK-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-benzylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 YUOCFEKWIWPITK-UHFFFAOYSA-N 0.000 claims description 5
- SGQKTIWTZZVBHS-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-benzylsulfonylpyrrolidin-3-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CN(CC2)S(=O)(=O)CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 SGQKTIWTZZVBHS-UHFFFAOYSA-N 0.000 claims description 5
- GUTRQDMDMYZGES-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-butylsulfonylpiperidin-3-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound C1N(S(=O)(=O)CCCC)CCCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 GUTRQDMDMYZGES-UHFFFAOYSA-N 0.000 claims description 5
- HQNAVRIDVCVQQZ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-butylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound C1CN(S(=O)(=O)CCCC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 HQNAVRIDVCVQQZ-UHFFFAOYSA-N 0.000 claims description 5
- IEMNRBMFCIUNGS-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-butylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]pyridine Chemical compound C1CN(S(=O)(=O)CCCC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 IEMNRBMFCIUNGS-UHFFFAOYSA-N 0.000 claims description 5
- CWPONJIVPGFGOA-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-butylsulfonylpyrrolidin-3-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound C1N(S(=O)(=O)CCCC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 CWPONJIVPGFGOA-UHFFFAOYSA-N 0.000 claims description 5
- ADEUXTLXWVFLME-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-ethylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound C1CN(S(=O)(=O)CC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 ADEUXTLXWVFLME-UHFFFAOYSA-N 0.000 claims description 5
- WKHVJQNTICLHHP-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-ethylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]pyridine Chemical compound C1CN(S(=O)(=O)CC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 WKHVJQNTICLHHP-UHFFFAOYSA-N 0.000 claims description 5
- SNYRGCFIRFHTBD-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-methylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]pyridine Chemical compound C1CN(S(=O)(=O)C)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 SNYRGCFIRFHTBD-UHFFFAOYSA-N 0.000 claims description 5
- BXUBKWMJQNIVNK-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-methylsulfonylpyrrolidin-3-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CN(CC2)S(C)(=O)=O)C=2C=C3OCOC3=CC=2)=N1 BXUBKWMJQNIVNK-UHFFFAOYSA-N 0.000 claims description 5
- DXBVGXRVODZVNR-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-propan-2-ylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound C1CN(S(=O)(=O)C(C)C)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 DXBVGXRVODZVNR-UHFFFAOYSA-N 0.000 claims description 5
- YBQSOTUUSVQSDX-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-propan-2-ylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]pyridine Chemical compound C1CN(S(=O)(=O)C(C)C)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 YBQSOTUUSVQSDX-UHFFFAOYSA-N 0.000 claims description 5
- WFAFZVJXDCKORT-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-propylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound C1CN(S(=O)(=O)CCC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 WFAFZVJXDCKORT-UHFFFAOYSA-N 0.000 claims description 5
- AQCMMAOQMOKPJQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-thiophen-2-ylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C=2SC=CC=2)C=2C=C3OCOC3=CC=2)=N1 AQCMMAOQMOKPJQ-UHFFFAOYSA-N 0.000 claims description 5
- PBXFIFABKLKBKE-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-thiophen-3-ylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C2=CSC=C2)C=2C=C3OCOC3=CC=2)=N1 PBXFIFABKLKBKE-UHFFFAOYSA-N 0.000 claims description 5
- JWWQUDKZMQCNNI-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(1-methylimidazol-4-yl)sulfonylpyrrolidin-3-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CN(CC2)S(=O)(=O)C=2N=CN(C)C=2)C=2C=C3OCOC3=CC=2)=N1 JWWQUDKZMQCNNI-UHFFFAOYSA-N 0.000 claims description 5
- WIESZJDBWQBFCO-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(2-naphthalen-1-ylethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C=1C=CC2=CC=CC=C2C=1CCS(=O)(=O)N(CC1)CCC1C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC=N1 WIESZJDBWQBFCO-UHFFFAOYSA-N 0.000 claims description 5
- CHISAJWFSHSAGP-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(2-naphthalen-2-ylethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CCC=2C=C3C=CC=CC3=CC=2)C=2C=C3OCOC3=CC=2)=N1 CHISAJWFSHSAGP-UHFFFAOYSA-N 0.000 claims description 5
- NIVOFZWVKLYSMZ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(2-phenylethenylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C=CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 NIVOFZWVKLYSMZ-UHFFFAOYSA-N 0.000 claims description 5
- HLLZYGDCAIEDSD-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(2-phenylethenylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1S(=O)(=O)C=CC1=CC=CC=C1 HLLZYGDCAIEDSD-UHFFFAOYSA-N 0.000 claims description 5
- DKBOGMRTFOKIEM-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(2-phenylethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1S(=O)(=O)CCC1=CC=CC=C1 DKBOGMRTFOKIEM-UHFFFAOYSA-N 0.000 claims description 5
- ZTIDOCNVLREPJM-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(3,4-dichlorophenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C=2C=C(Cl)C(Cl)=CC=2)C=2C=C3OCOC3=CC=2)=N1 ZTIDOCNVLREPJM-UHFFFAOYSA-N 0.000 claims description 5
- UYMPGKGTHHSJND-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(3,4-dichlorophenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1S(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 UYMPGKGTHHSJND-UHFFFAOYSA-N 0.000 claims description 5
- FJTQBZQIVAMWKJ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-chlorophenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C=2C=CC(Cl)=CC=2)C=2C=C3OCOC3=CC=2)=N1 FJTQBZQIVAMWKJ-UHFFFAOYSA-N 0.000 claims description 5
- DDWDJRWPMOQIFD-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-chlorophenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 DDWDJRWPMOQIFD-UHFFFAOYSA-N 0.000 claims description 5
- WQRSAMRRRMOASD-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-chlorophenyl)sulfonylpyrrolidin-3-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CN(CC2)S(=O)(=O)C=2C=CC(Cl)=CC=2)C=2C=C3OCOC3=CC=2)=N1 WQRSAMRRRMOASD-UHFFFAOYSA-N 0.000 claims description 5
- MPODDBWOVRLHKU-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-methoxyphenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 MPODDBWOVRLHKU-UHFFFAOYSA-N 0.000 claims description 5
- IZSKNMHGLYPANF-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-methylphenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 IZSKNMHGLYPANF-UHFFFAOYSA-N 0.000 claims description 5
- DUFDYJBGCYXACR-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-phenoxyphenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C=2C=CC(OC=3C=CC=CC=3)=CC=2)C=2C=C3OCOC3=CC=2)=N1 DUFDYJBGCYXACR-UHFFFAOYSA-N 0.000 claims description 5
- JMKJVYXTWYNLEK-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C=2C=CC(=CC=2)C=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 JMKJVYXTWYNLEK-UHFFFAOYSA-N 0.000 claims description 5
- QNWJZGWOVACKLE-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(cyclohexylmethyl)piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1CC1CCCCC1 QNWJZGWOVACKLE-UHFFFAOYSA-N 0.000 claims description 5
- FZEZTGKNVDQBCE-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(pyridin-2-ylmethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2N=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 FZEZTGKNVDQBCE-UHFFFAOYSA-N 0.000 claims description 5
- SATHLSRFOICFMQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(pyridin-3-ylmethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=NC=CC=2)C=2C=C3OCOC3=CC=2)=N1 SATHLSRFOICFMQ-UHFFFAOYSA-N 0.000 claims description 5
- WSMSMYWLCAAAKS-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound O1C(C)(C)OCC1CN1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 WSMSMYWLCAAAKS-UHFFFAOYSA-N 0.000 claims description 5
- BSACKBHLZQSGCB-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(2-nitrophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound [O-][N+](=O)C1=CC=CC=C1CS(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 BSACKBHLZQSGCB-UHFFFAOYSA-N 0.000 claims description 5
- XHVXAVMCXRSSIJ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(3,4-dichlorophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=C(Cl)C(Cl)=CC=C1CS(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 XHVXAVMCXRSSIJ-UHFFFAOYSA-N 0.000 claims description 5
- MPSCSDJNRHTYAK-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(3,5-dichlorophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound ClC1=CC(Cl)=CC(CS(=O)(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)=C1 MPSCSDJNRHTYAK-UHFFFAOYSA-N 0.000 claims description 5
- VEDFSRDPRBIAHR-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(3,5-difluorophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound FC1=CC(F)=CC(CS(=O)(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)=C1 VEDFSRDPRBIAHR-UHFFFAOYSA-N 0.000 claims description 5
- DAQSRPVCLQSDTE-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(4-chlorophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(Cl)=CC=C1CS(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 DAQSRPVCLQSDTE-UHFFFAOYSA-N 0.000 claims description 5
- QPDBYYHHNUCVME-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(4-methylphenyl)methyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(C)=CC=C1CN1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 QPDBYYHHNUCVME-UHFFFAOYSA-N 0.000 claims description 5
- OGRVREHRYLXFIJ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[[3,5-bis(trifluoromethyl)phenyl]methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(CS(=O)(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)=C1 OGRVREHRYLXFIJ-UHFFFAOYSA-N 0.000 claims description 5
- VCZVKWZFYAUTMB-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[[3-(trifluoromethyl)phenyl]methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=C(C=CC=2)C(F)(F)F)C=2C=C3OCOC3=CC=2)=N1 VCZVKWZFYAUTMB-UHFFFAOYSA-N 0.000 claims description 5
- QOLBRKVCDJBHLM-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[[3-fluoro-5-(trifluoromethyl)phenyl]methyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound FC(F)(F)C1=CC(F)=CC(CN2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)=C1 QOLBRKVCDJBHLM-UHFFFAOYSA-N 0.000 claims description 5
- KPXYXCVXSFYBBO-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[[4-(trifluoromethyl)phenyl]methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(C(F)(F)F)=CC=C1CS(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 KPXYXCVXSFYBBO-UHFFFAOYSA-N 0.000 claims description 5
- KLGKGHCBTZTAGG-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[4-(sulfamoylamino)-1-bicyclo[2.2.2]octanyl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(N)(=O)=O)C=2C=C3OCOC3=CC=2)=N1 KLGKGHCBTZTAGG-UHFFFAOYSA-N 0.000 claims description 5
- KHDKNUGNYWMNRU-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-piperidin-4-yl-1h-imidazol-5-yl]pyridine Chemical compound C1=C2OCOC2=CC=C1C=1N=C(C2CCNCC2)NC=1C1=CC=CC=N1 KHDKNUGNYWMNRU-UHFFFAOYSA-N 0.000 claims description 5
- OUISUIBLHNSWMA-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]acetonitrile Chemical compound CC1=CC=CC(C=2C(=CN(CC#N)N=2)C=2C=C3OCOC3=CC=2)=N1 OUISUIBLHNSWMA-UHFFFAOYSA-N 0.000 claims description 5
- GEGAGIPGIGCNRW-UHFFFAOYSA-N 2-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-1h-pyrazol-5-yl]pyridine Chemical compound C=1C=C2OCCOC2=CC=1C1=CNN=C1C1=CC=CC=N1 GEGAGIPGIGCNRW-UHFFFAOYSA-N 0.000 claims description 5
- OBKNPOIEIDWLFN-UHFFFAOYSA-N 2-[4-(2,3-dihydro-1-benzofuran-5-yl)-1h-pyrazol-5-yl]pyridine Chemical compound C=1C=C2OCCC2=CC=1C1=CNN=C1C1=CC=CC=N1 OBKNPOIEIDWLFN-UHFFFAOYSA-N 0.000 claims description 5
- HTLSOALCDIEOBI-UHFFFAOYSA-N 2-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]acetic acid Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC(O)=O)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 HTLSOALCDIEOBI-UHFFFAOYSA-N 0.000 claims description 5
- WTMCRVJVKGKDOO-UHFFFAOYSA-N 2-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]acetonitrile Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC#N)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 WTMCRVJVKGKDOO-UHFFFAOYSA-N 0.000 claims description 5
- FVJFPPZGRCXFRL-UHFFFAOYSA-N 2-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidin-1-yl]sulfonylmethyl]aniline Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C(=CC=CC=2)N)C=2C=C3OCOC3=CC=2)=N1 FVJFPPZGRCXFRL-UHFFFAOYSA-N 0.000 claims description 5
- IHWIMLMSJKMBBR-UHFFFAOYSA-N 2-methyl-4-methylsulfanyl-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)pyrimidine Chemical compound CC1=NC(SC)=CC(C=2C(=NNC=2)C=2N=CC=CC=2)=N1 IHWIMLMSJKMBBR-UHFFFAOYSA-N 0.000 claims description 5
- QGAGLWKUTXHKMN-UHFFFAOYSA-N 2-methyl-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1N2N=C(C)N=C2C=CC=1C1=CNN=C1C1=CC=CC=N1 QGAGLWKUTXHKMN-UHFFFAOYSA-N 0.000 claims description 5
- IDWPHPUVJLLXHG-UHFFFAOYSA-N 3,3-dimethyl-n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]butanamide Chemical compound CSC1=NC=CC(C=2N3C=CC(NC(=O)CC(C)(C)C)=NC3=NC=2C=2N=C(C)C=CC=2)=N1 IDWPHPUVJLLXHG-UHFFFAOYSA-N 0.000 claims description 5
- SRUUQKVZNDNFFD-UHFFFAOYSA-N 3,3-dimethyl-n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]butanamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(NC(=O)CC(C)(C)C)=NC3=N2)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 SRUUQKVZNDNFFD-UHFFFAOYSA-N 0.000 claims description 5
- NQGDNOYOIMCELQ-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)-n-(2-oxo-2-pyridin-3-ylethyl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NCC(=O)C=2C=NC=CC=2)C=2N=C(N)N=CC=2)=N1 NQGDNOYOIMCELQ-UHFFFAOYSA-N 0.000 claims description 5
- ZSGAZWNRAGROEO-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)-n-(piperidin-3-ylmethyl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NCC2CNCCC2)C=2N=C(N)N=CC=2)=N1 ZSGAZWNRAGROEO-UHFFFAOYSA-N 0.000 claims description 5
- DYTLNCMKOFYAIP-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)-n-methylsulfonylimidazo[1,2-a]pyridine-6-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C(=O)NS(C)(=O)=O)C=2N=C(N)N=CC=2)=N1 DYTLNCMKOFYAIP-UHFFFAOYSA-N 0.000 claims description 5
- PMPGOGWILLVGCS-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-8-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=C(N)C3=N2)C=2N=C(N)N=CC=2)=N1 PMPGOGWILLVGCS-UHFFFAOYSA-N 0.000 claims description 5
- BAUQEWQBBHXUMG-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carbonitrile Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C#N)C=2N=C(N)N=CC=2)=N1 BAUQEWQBBHXUMG-UHFFFAOYSA-N 0.000 claims description 5
- WBSWEUKONANKOY-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(N)=O)C=2N=C(N)N=CC=2)=N1 WBSWEUKONANKOY-UHFFFAOYSA-N 0.000 claims description 5
- JJRWXPAUYRHWSS-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidin-7-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC(N)=NC3=N2)C=2N=C(N)N=CC=2)=N1 JJRWXPAUYRHWSS-UHFFFAOYSA-N 0.000 claims description 5
- DZYLDAACLSDXJN-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-6-methyl-2-(6-methylpyridin-2-yl)-n-(2-pyridin-4-ylethyl)imidazo[1,2-a]pyridin-8-amine Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(N)N=CC=3)N2C=C(C)C=C1NCCC1=CC=NC=C1 DZYLDAACLSDXJN-UHFFFAOYSA-N 0.000 claims description 5
- VJJLFUGNAPGFAM-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-N-hydroxy-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C(=O)NO)C=2N=C(N)N=CC=2)=N1 VJJLFUGNAPGFAM-UHFFFAOYSA-N 0.000 claims description 5
- DZASFVSKVJGYPH-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-N-hydroxy-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NO)C=2N=C(N)N=CC=2)=N1 DZASFVSKVJGYPH-UHFFFAOYSA-N 0.000 claims description 5
- VKODDBPPNQPIEV-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n',n'-dimethyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carbohydrazide Chemical compound N1=C2C=C(C(=O)NN(C)C)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 VKODDBPPNQPIEV-UHFFFAOYSA-N 0.000 claims description 5
- WOBVNDLMPGASJH-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-(2-methoxyethyl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound N12C=C(C(=O)NCCOC)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(N)=N1 WOBVNDLMPGASJH-UHFFFAOYSA-N 0.000 claims description 5
- DSZXRZARDVKLEJ-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-[2-(dimethylamino)ethyl]-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound N1=C2C=C(C(=O)NCCN(C)C)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 DSZXRZARDVKLEJ-UHFFFAOYSA-N 0.000 claims description 5
- HWDOSLVNGNQUSJ-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-cyclopropyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C(=O)NC2CC2)C=2N=C(N)N=CC=2)=N1 HWDOSLVNGNQUSJ-UHFFFAOYSA-N 0.000 claims description 5
- KEVVIUGJRUOWCB-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-cyclopropyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NC2CC2)C=2N=C(N)N=CC=2)=N1 KEVVIUGJRUOWCB-UHFFFAOYSA-N 0.000 claims description 5
- WNOGQPVYYPDYIN-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-ethyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound N12C=C(C(=O)NCC)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(N)=N1 WNOGQPVYYPDYIN-UHFFFAOYSA-N 0.000 claims description 5
- PTALXKKEJWSJGX-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-ethyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound N1=C2C=C(C(=O)NCC)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 PTALXKKEJWSJGX-UHFFFAOYSA-N 0.000 claims description 5
- RIHSPLOZUDDXSE-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-methoxy-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound N12C=C(C(=O)NOC)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(N)=N1 RIHSPLOZUDDXSE-UHFFFAOYSA-N 0.000 claims description 5
- AMODHECBNXJGPF-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-methoxy-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound N1=C2C=C(C(=O)NOC)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 AMODHECBNXJGPF-UHFFFAOYSA-N 0.000 claims description 5
- ZFGJPLYSVPCNAA-UHFFFAOYSA-N 3-(2-methylsulfanylpyrimidin-4-yl)-2-pyridin-2-ylimidazo[1,2-a]pyridine Chemical compound CSC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=CC=CC=2)=N1 ZFGJPLYSVPCNAA-UHFFFAOYSA-N 0.000 claims description 5
- MIJYWKSDJJUTCG-UHFFFAOYSA-N 3-(3-methoxyphenyl)-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2,1-benzoxazole Chemical compound COC1=CC=CC(C2=C3C=C(C=CC3=NO2)C2=C(NN=C2)C=2N=CC=CC=2)=C1 MIJYWKSDJJUTCG-UHFFFAOYSA-N 0.000 claims description 5
- PKYNGYYFDJWSPD-UHFFFAOYSA-N 3-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)propan-1-amine Chemical compound N=1N(CCCN)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 PKYNGYYFDJWSPD-UHFFFAOYSA-N 0.000 claims description 5
- GKMSJYFFCJBASE-UHFFFAOYSA-N 3-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)propanoic acid Chemical compound N=1N(CCC(=O)O)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 GKMSJYFFCJBASE-UHFFFAOYSA-N 0.000 claims description 5
- OVWQVJJJLDIODX-UHFFFAOYSA-N 3-(4-chlorophenyl)-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2,1-benzoxazole Chemical compound C1=CC(Cl)=CC=C1C1=C2C=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=CC2=NO1 OVWQVJJJLDIODX-UHFFFAOYSA-N 0.000 claims description 5
- JGJUOHQSJQGVKB-UHFFFAOYSA-N 3-(4-ethylphenyl)-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2,1-benzoxazole Chemical compound C1=CC(CC)=CC=C1C1=C2C=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=CC2=NO1 JGJUOHQSJQGVKB-UHFFFAOYSA-N 0.000 claims description 5
- VKVHXDKKGYMTPU-UHFFFAOYSA-N 3-(4-methoxyphenyl)-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2,1-benzoxazole Chemical compound C1=CC(OC)=CC=C1C1=C2C=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=CC2=NO1 VKVHXDKKGYMTPU-UHFFFAOYSA-N 0.000 claims description 5
- VCIAFTLLDVOKLY-UHFFFAOYSA-N 3-[(4-nitrophenyl)methyl]-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1C(=O)C2=CC(C=3C(=NNC=3)C=3N=CC=CC=3)=CC=C2N=C1 VCIAFTLLDVOKLY-UHFFFAOYSA-N 0.000 claims description 5
- CRXCBJUEAVHWOS-UHFFFAOYSA-N 3-[2-(2-methylaziridin-1-yl)pyrimidin-4-yl]-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine Chemical compound CC1CN1C1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 CRXCBJUEAVHWOS-UHFFFAOYSA-N 0.000 claims description 5
- ITDLSWQHTALTPU-UHFFFAOYSA-N 3-[2-(azetidin-1-yl)pyrimidin-4-yl]-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N=CC=2)N2CCC2)=N1 ITDLSWQHTALTPU-UHFFFAOYSA-N 0.000 claims description 5
- GYSJFFZLKJKITE-UHFFFAOYSA-N 3-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]propanenitrile Chemical compound CC1=CC=CC(C=2C(=CN(CCC#N)N=2)C=2C=C3OCOC3=CC=2)=N1 GYSJFFZLKJKITE-UHFFFAOYSA-N 0.000 claims description 5
- KWAPKVNILUFYMY-UHFFFAOYSA-N 3-methyl-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-one Chemical compound C1=C2C(=O)N(C)C=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 KWAPKVNILUFYMY-UHFFFAOYSA-N 0.000 claims description 5
- YBHYZXZQTQWBQB-UHFFFAOYSA-N 3-methyl-6-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]quinazolin-4-one Chemical compound CC1=CC=CC(C=2C(=CNN=2)C=2C=C3C(=O)N(C)C=NC3=CC=2)=N1 YBHYZXZQTQWBQB-UHFFFAOYSA-N 0.000 claims description 5
- UDWZGKJGQUDLSG-UHFFFAOYSA-N 4-(2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)-n-(pyridin-3-ylmethyl)pyrimidin-2-amine Chemical compound C=1C=CN=CC=1CNC(N=1)=NC=CC=1C(N1C=CC=CC1=N1)=C1C1=CC=CC=N1 UDWZGKJGQUDLSG-UHFFFAOYSA-N 0.000 claims description 5
- IUXZYJGBRTUWHZ-UHFFFAOYSA-N 4-(2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)pyrimidin-2-amine Chemical compound NC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=CC=CC=2)=N1 IUXZYJGBRTUWHZ-UHFFFAOYSA-N 0.000 claims description 5
- OKLAIKUJFGYQNY-UHFFFAOYSA-N 4-(2-pyridin-2-ylpyrazolo[1,5-a]pyridin-3-yl)pyrimidin-2-amine Chemical compound NC1=NC=CC(C2=C3C=CC=CN3N=C2C=2N=CC=CC=2)=N1 OKLAIKUJFGYQNY-UHFFFAOYSA-N 0.000 claims description 5
- LORWLLUMJKJESN-UHFFFAOYSA-N 4-(4-methoxyphenyl)-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazoline Chemical compound C1=CC(OC)=CC=C1C1=NC=NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C12 LORWLLUMJKJESN-UHFFFAOYSA-N 0.000 claims description 5
- XEQUMANZORSJSQ-UHFFFAOYSA-N 4-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2h-isoquinolin-1-one Chemical compound C12=CC=CC=C2C(=O)NC=C1C1=CNN=C1C1=CC=CC=N1 XEQUMANZORSJSQ-UHFFFAOYSA-N 0.000 claims description 5
- HJWAOCQEWUVDQM-UHFFFAOYSA-N 4-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2h-phthalazin-1-one Chemical compound C12=CC=CC=C2C(=O)NN=C1C1=CNN=C1C1=CC=CC=N1 HJWAOCQEWUVDQM-UHFFFAOYSA-N 0.000 claims description 5
- QTIQBUCPHAGXIX-UHFFFAOYSA-N 4-[2-(1-benzylsulfonylpiperidin-4-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-4-yl]-n-[(4-methoxyphenyl)methyl]pyridin-2-amine Chemical compound C1=CC(OC)=CC=C1CNC1=CC(C2=C(NC(=N2)C2CCN(CC2)S(=O)(=O)CC=2C=CC=CC=2)C=2N=C(C)C=CC=2)=CC=N1 QTIQBUCPHAGXIX-UHFFFAOYSA-N 0.000 claims description 5
- ZJRFSDKQGLOMFX-UHFFFAOYSA-N 4-[2-(1-butylsulfonylpiperidin-4-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-4-yl]pyridin-2-amine Chemical compound C1CN(S(=O)(=O)CCCC)CCC1C1=NC(C=2C=C(N)N=CC=2)=C(C=2N=C(C)C=CC=2)N1 ZJRFSDKQGLOMFX-UHFFFAOYSA-N 0.000 claims description 5
- YBHWFXBSFOTTDF-UHFFFAOYSA-N 4-[2-(6-chloropyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound NC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(Cl)C=CC=2)=N1 YBHWFXBSFOTTDF-UHFFFAOYSA-N 0.000 claims description 5
- UCEORFVRGDPMJZ-UHFFFAOYSA-N 4-[2-(6-chloropyridin-2-yl)pyrazolo[1,5-c]pyrimidin-3-yl]pyrimidin-2-amine Chemical compound NC1=NC=CC(C2=C3C=CN=CN3N=C2C=2N=C(Cl)C=CC=2)=N1 UCEORFVRGDPMJZ-UHFFFAOYSA-N 0.000 claims description 5
- ZIKNHXBNMFKMFV-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(2-morpholin-4-ylethyl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCN3CCOCC3)N=CC=2)=N1 ZIKNHXBNMFKMFV-UHFFFAOYSA-N 0.000 claims description 5
- UMUBGGWVFYWKPC-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(2-pyridin-2-ylethyl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCC=3N=CC=CC=3)N=CC=2)=N1 UMUBGGWVFYWKPC-UHFFFAOYSA-N 0.000 claims description 5
- XRHDZRZVBYMLHG-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(2-pyridin-3-ylethyl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCC=3C=NC=CC=3)N=CC=2)=N1 XRHDZRZVBYMLHG-UHFFFAOYSA-N 0.000 claims description 5
- PGEFNWQUJQHPLE-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(2-pyridin-4-ylethyl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCC=3C=CN=CC=3)N=CC=2)=N1 PGEFNWQUJQHPLE-UHFFFAOYSA-N 0.000 claims description 5
- WNHKNNXDZWKEPX-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(2h-tetrazol-5-yl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NC=3NN=NN=3)N=CC=2)=N1 WNHKNNXDZWKEPX-UHFFFAOYSA-N 0.000 claims description 5
- OXNVLQQCADIKLE-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(3-morpholin-4-ylpropyl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCN3CCOCC3)N=CC=2)=N1 OXNVLQQCADIKLE-UHFFFAOYSA-N 0.000 claims description 5
- DKWLODKAWHEALD-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(3-piperidin-1-ylpropyl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCN3CCCCC3)N=CC=2)=N1 DKWLODKAWHEALD-UHFFFAOYSA-N 0.000 claims description 5
- VHVLKQPXJUKJFV-GOSISDBHSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-[(1r)-1-phenylethyl]pyrimidin-2-amine Chemical compound N([C@H](C)C=1C=CC=CC=1)C(N=1)=NC=CC=1C(N1C=CC=CC1=N1)=C1C1=CC=CC(C)=N1 VHVLKQPXJUKJFV-GOSISDBHSA-N 0.000 claims description 5
- GLWTXYIDCICEOP-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-propan-2-ylpyrimidin-2-amine Chemical compound CC(C)NC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 GLWTXYIDCICEOP-UHFFFAOYSA-N 0.000 claims description 5
- UDPIROHVSULNKG-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N)N=CC=2)=N1 UDPIROHVSULNKG-UHFFFAOYSA-N 0.000 claims description 5
- AMZCVYMZEGXAJP-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidine-2-carbonitrile Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N=CC=2)C#N)=N1 AMZCVYMZEGXAJP-UHFFFAOYSA-N 0.000 claims description 5
- PUMALOKTAVGLKL-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidine-2-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N=CC=2)C(N)=O)=N1 PUMALOKTAVGLKL-UHFFFAOYSA-N 0.000 claims description 5
- QMGFXZTTZWZHID-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)pyrazolo[1,5-a]pyrazin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C=2C(=C3C=NC=CN3N=2)C=2N=C(N)N=CC=2)=N1 QMGFXZTTZWZHID-UHFFFAOYSA-N 0.000 claims description 5
- FSMFIPLMGNQWQW-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)pyrazolo[1,5-a]pyrimidin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C=2C(=C3N=CC=CN3N=2)C=2N=C(N)N=CC=2)=N1 FSMFIPLMGNQWQW-UHFFFAOYSA-N 0.000 claims description 5
- MHSGTSAQVXECLK-UHFFFAOYSA-N 4-[2-[2-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]ethoxy]ethoxy]bicyclo[2.2.2]octane-1-carboxylic acid Chemical compound CC1=CC=CC(C=2C(=CN(CCOCCOC34CCC(CC3)(CC4)C(O)=O)N=2)C=2C=C3OCOC3=CC=2)=N1 MHSGTSAQVXECLK-UHFFFAOYSA-N 0.000 claims description 5
- YECDPLLJCMSCJW-UHFFFAOYSA-N 4-[3-pyridin-2-yl-1-(3-pyrrolidin-1-ylpropyl)pyrazol-4-yl]quinoline Chemical compound C1=C(C=2C3=CC=CC=C3N=CC=2)C(C=2N=CC=CC=2)=NN1CCCN1CCCC1 YECDPLLJCMSCJW-UHFFFAOYSA-N 0.000 claims description 5
- ZUJOXLNMLFTWFC-UHFFFAOYSA-N 4-[3-pyridin-2-yl-1-[2-(2h-tetrazol-5-yl)ethyl]pyrazol-4-yl]quinoline Chemical compound N1=NNN=C1CCN(N=1)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 ZUJOXLNMLFTWFC-UHFFFAOYSA-N 0.000 claims description 5
- AHSRGISWCAGSEM-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-2-(trifluoromethyl)pyrimidine Chemical compound FC(F)(F)C1=NC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 AHSRGISWCAGSEM-UHFFFAOYSA-N 0.000 claims description 5
- NOYRGTIDHSIQDF-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-2-methylpyrimidine Chemical compound CC1=NC=CC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=N1 NOYRGTIDHSIQDF-UHFFFAOYSA-N 0.000 claims description 5
- YIQGAYJYTUYZAB-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]cyclohexan-1-amine Chemical compound CC1=CC=CC(C=2C(=CN(N=2)C2CCC(N)CC2)C=2C=C3OCOC3=CC=2)=N1 YIQGAYJYTUYZAB-UHFFFAOYSA-N 0.000 claims description 5
- IITIZYRMDPTJAP-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-(2-methylsulfanylpyrimidin-4-yl)-1h-imidazol-2-yl]benzamide Chemical compound CSC1=NC=CC(C2=C(N=C(N2)C=2C=CC(=CC=2)C(N)=O)C=2C=C3OCOC3=CC=2)=N1 IITIZYRMDPTJAP-UHFFFAOYSA-N 0.000 claims description 5
- PNFODLUWBLVNJD-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-(2-methylsulfanylpyrimidin-4-yl)-1h-imidazol-2-yl]benzonitrile Chemical compound CSC1=NC=CC(C2=C(N=C(N2)C=2C=CC(=CC=2)C#N)C=2C=C3OCOC3=CC=2)=N1 PNFODLUWBLVNJD-UHFFFAOYSA-N 0.000 claims description 5
- UREOYJDBSNWAOP-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexan-1-amine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(N)CC2)C=2C=C3OCOC3=CC=2)=N1 UREOYJDBSNWAOP-UHFFFAOYSA-N 0.000 claims description 5
- HRGIAZJKJVXATI-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-2h-imidazol-2-yl]-n,n-dimethylpiperidine-1-sulfonamide Chemical compound C1CN(S(=O)(=O)N(C)C)CCC1C1N=C(C=2N=C(C)C=CC=2)C(C=2C=C3OCOC3=CC=2)=N1 HRGIAZJKJVXATI-UHFFFAOYSA-N 0.000 claims description 5
- ZTNXYHHZJXGCJP-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]-n-[(2,4-dichlorophenyl)methyl]piperidine-1-carboxamide Chemical compound ClC1=CC(Cl)=CC=C1CNC(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 ZTNXYHHZJXGCJP-UHFFFAOYSA-N 0.000 claims description 5
- JLVJKUWRYNTZKQ-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]-n-[(2-chlorophenyl)methyl]piperidine-1-carboxamide Chemical compound ClC1=CC=CC=C1CNC(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 JLVJKUWRYNTZKQ-UHFFFAOYSA-N 0.000 claims description 5
- HHTYORXLPPYWAD-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]-n-[(3-fluorophenyl)methyl]piperidine-1-carboxamide Chemical compound FC1=CC=CC(CNC(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)=C1 HHTYORXLPPYWAD-UHFFFAOYSA-N 0.000 claims description 5
- PYXXJCQYVKRWTJ-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]-n-[(4-fluorophenyl)methyl]piperidine-1-carboxamide Chemical compound C1=CC(F)=CC=C1CNC(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 PYXXJCQYVKRWTJ-UHFFFAOYSA-N 0.000 claims description 5
- LDQVZEVRSYWYTL-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]-n-[(4-methoxyphenyl)methyl]piperidine-1-carboxamide Chemical compound C1=CC(OC)=CC=C1CNC(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 LDQVZEVRSYWYTL-UHFFFAOYSA-N 0.000 claims description 5
- ISBORYSXADEHMA-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]-n-[(4-methylphenyl)methyl]piperidine-1-carboxamide Chemical compound C1=CC(C)=CC=C1CNC(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 ISBORYSXADEHMA-UHFFFAOYSA-N 0.000 claims description 5
- BCYZNZMXANPOKW-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]-n-benzylpiperidine-1-carboxamide Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1C(=O)NCC1=CC=CC=C1 BCYZNZMXANPOKW-UHFFFAOYSA-N 0.000 claims description 5
- FRJGDMVGTXTZSH-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidine-1-carboxamide Chemical compound C1CN(C(=O)N)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 FRJGDMVGTXTZSH-UHFFFAOYSA-N 0.000 claims description 5
- QRRMLTSYWBBKFI-UHFFFAOYSA-N 4-[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]sulfonylbenzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1S(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 QRRMLTSYWBBKFI-UHFFFAOYSA-N 0.000 claims description 5
- VSQHYECTXDPPSE-UHFFFAOYSA-N 4-[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]sulfonylbenzonitrile Chemical compound C=1C=C(C#N)C=CC=1S(=O)(=O)N(CC1)CCC1C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC=N1 VSQHYECTXDPPSE-UHFFFAOYSA-N 0.000 claims description 5
- CVHYJFJDSMSYGH-UHFFFAOYSA-N 4-[5-(2-methylpyrimidin-4-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]cyclohexan-1-ol Chemical compound CC1=NC=CC(C2=C(N=C(N2)C2CCC(O)CC2)C=2C=C3N=CC=NC3=CC=2)=N1 CVHYJFJDSMSYGH-UHFFFAOYSA-N 0.000 claims description 5
- SJANNJAOQJMQHI-UHFFFAOYSA-N 4-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]-2-methylsulfanylpyrimidine Chemical compound CSC1=NC=CC(C=2C(=NNC=2)C=2N=C(C)C=CC=2)=N1 SJANNJAOQJMQHI-UHFFFAOYSA-N 0.000 claims description 5
- RFDFWKWWEIPCNH-UHFFFAOYSA-N 4-[6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-yl]morpholine Chemical compound C1COCCN1C1=NC=NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C12 RFDFWKWWEIPCNH-UHFFFAOYSA-N 0.000 claims description 5
- XBQDWPKMVWEZHR-UHFFFAOYSA-N 4-[6-chloro-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=C(Cl)C=CC3=N2)C=2N=C(N)N=CC=2)=N1 XBQDWPKMVWEZHR-UHFFFAOYSA-N 0.000 claims description 5
- OARUIIZSOREFDH-UHFFFAOYSA-N 4-[6-fluoro-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=C(F)C=CC3=N2)C=2N=C(N)N=CC=2)=N1 OARUIIZSOREFDH-UHFFFAOYSA-N 0.000 claims description 5
- ZYRJAHHKBMBPCR-UHFFFAOYSA-N 4-[6-methyl-2-(6-methylpyridin-2-yl)-8-morpholin-4-ylimidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(N)N=CC=3)N2C=C(C)C=C1N1CCOCC1 ZYRJAHHKBMBPCR-UHFFFAOYSA-N 0.000 claims description 5
- SIRPCTMBJICDAX-UHFFFAOYSA-N 4-[6-methyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound N12C=C(C)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(N)=N1 SIRPCTMBJICDAX-UHFFFAOYSA-N 0.000 claims description 5
- BVOUXZMZTDMVGT-UHFFFAOYSA-N 4-[7-methyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound N1=C2C=C(C)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 BVOUXZMZTDMVGT-UHFFFAOYSA-N 0.000 claims description 5
- BPNIKRRCKQDOMY-UHFFFAOYSA-N 4-[8-methyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=C(C)C3=N2)C=2N=C(N)N=CC=2)=N1 BPNIKRRCKQDOMY-UHFFFAOYSA-N 0.000 claims description 5
- BQRGKTFOVBEAPO-UHFFFAOYSA-N 4-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidin-1-yl]sulfonylmethyl]-7,7-dimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC23C(CC(CC2)C3(C)C)=O)C=2C=C3OCOC3=CC=2)=N1 BQRGKTFOVBEAPO-UHFFFAOYSA-N 0.000 claims description 5
- CXJKVETXNJOEHR-UHFFFAOYSA-N 4-[[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]sulfonylmethyl]-7,7-dimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(CC2=O)CCC12CS(=O)(=O)N(CC1)CCC1C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC=N1 CXJKVETXNJOEHR-UHFFFAOYSA-N 0.000 claims description 5
- RRLJBZBOHXRYQY-UHFFFAOYSA-N 4-methoxy-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazoline Chemical compound C1=C2C(OC)=NC=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 RRLJBZBOHXRYQY-UHFFFAOYSA-N 0.000 claims description 5
- HMRHYCIZYFEYPS-UHFFFAOYSA-N 4-methyl-7-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1,3-dihydro-1,4-benzodiazepine-2,5-dione Chemical compound C1=C2C(=O)N(C)CC(=O)NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 HMRHYCIZYFEYPS-UHFFFAOYSA-N 0.000 claims description 5
- RLNFSLBMZBXJOR-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1,2-benzoxazole Chemical compound C1=C2C=NOC2=CC=C1C1=CNN=C1C1=CC=CC=N1 RLNFSLBMZBXJOR-UHFFFAOYSA-N 0.000 claims description 5
- IXIWVJRDBMRDKT-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1,3-benzoxazole Chemical compound C=1C=C2OC=NC2=CC=1C1=CNN=C1C1=CC=CC=N1 IXIWVJRDBMRDKT-UHFFFAOYSA-N 0.000 claims description 5
- QALIECXFYNVXDV-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazole-3-carboxylic acid Chemical compound C1=C2C(C(=O)O)=NNC2=CC=C1C=1C=NNC=1C1=CC=CC=N1 QALIECXFYNVXDV-UHFFFAOYSA-N 0.000 claims description 5
- RELRCIMXHZRDPH-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indole Chemical compound C=1C=C2NC=CC2=CC=1C1=CNN=C1C1=CC=CC=N1 RELRCIMXHZRDPH-UHFFFAOYSA-N 0.000 claims description 5
- AOCQNXGGMHUVMI-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2,1,3-benzothiadiazole Chemical compound C1=CC2=NSN=C2C=C1C1=CNN=C1C1=CC=CC=N1 AOCQNXGGMHUVMI-UHFFFAOYSA-N 0.000 claims description 5
- BJQFRDHFNOSUOI-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-2,1,3-benzoxadiazole Chemical compound C1=CC2=NON=C2C=C1C1=CNN=C1C1=CC=CC=N1 BJQFRDHFNOSUOI-UHFFFAOYSA-N 0.000 claims description 5
- GEGNAAVHSKDFJG-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-3-thiophen-3-yl-2,1-benzoxazole Chemical compound S1C=CC(C2=C3C=C(C=CC3=NO2)C=2C(=NNC=2)C=2N=CC=CC=2)=C1 GEGNAAVHSKDFJG-UHFFFAOYSA-N 0.000 claims description 5
- PENACLFHOFYJQA-UHFFFAOYSA-N 5-(5-pyridin-2-yl-1h-pyrazol-4-yl)pyridin-2-amine Chemical compound C1=NC(N)=CC=C1C1=C(C=2N=CC=CC=2)NN=C1 PENACLFHOFYJQA-UHFFFAOYSA-N 0.000 claims description 5
- FOIDCTICLKCJAX-UHFFFAOYSA-N 5-[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]sulfonyl-n,n-dimethylnaphthalen-1-amine Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)N(CC1)CCC1C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC=N1 FOIDCTICLKCJAX-UHFFFAOYSA-N 0.000 claims description 5
- UZPKOKMFDJQROV-UHFFFAOYSA-N 5-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]-2,1,3-benzothiadiazole Chemical compound CC1=CC=CC(C=2C(=CNN=2)C2=CC3=NSN=C3C=C2)=N1 UZPKOKMFDJQROV-UHFFFAOYSA-N 0.000 claims description 5
- ZZQJVHSWPITQLK-UHFFFAOYSA-N 5-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]-3-phenyl-2,1-benzoxazole Chemical compound CC1=CC=CC(C=2C(=CNN=2)C2=CC3=C(C=4C=CC=CC=4)ON=C3C=C2)=N1 ZZQJVHSWPITQLK-UHFFFAOYSA-N 0.000 claims description 5
- ZSMDWARKZLZBDN-UHFFFAOYSA-N 5-methyl-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=CC2=NC=NN2C(C)=C1C1=CNN=C1C1=CC=CC=N1 ZSMDWARKZLZBDN-UHFFFAOYSA-N 0.000 claims description 5
- RXXDYAWKHHAZHN-UHFFFAOYSA-N 5-methyl-n-[6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-yl]thiophene-2-carboxamide Chemical compound S1C(C)=CC=C1C(=O)NC1=NC=NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C12 RXXDYAWKHHAZHN-UHFFFAOYSA-N 0.000 claims description 5
- YXISXWPTVPNZSB-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-b]pyridazine Chemical compound N=1N2N=CN=C2C=CC=1C1=CNN=C1C1=CC=CC=N1 YXISXWPTVPNZSB-UHFFFAOYSA-N 0.000 claims description 5
- SFNKTPUJVDOOMX-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1,3-benzothiazole Chemical compound C1=C2SC=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 SFNKTPUJVDOOMX-UHFFFAOYSA-N 0.000 claims description 5
- MDUSFHREFMSKTH-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-quinazolin-4-one Chemical compound C1=C2C(=O)NC=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 MDUSFHREFMSKTH-UHFFFAOYSA-N 0.000 claims description 5
- NNVJHCATNYWLHR-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C=1N2N=CN=C2C=CC=1C1=CNN=C1C1=CC=CC=N1 NNVJHCATNYWLHR-UHFFFAOYSA-N 0.000 claims description 5
- PDNNXJMEHCBLDU-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-amine Chemical compound C1=C2C(N)=NC=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 PDNNXJMEHCBLDU-UHFFFAOYSA-N 0.000 claims description 5
- NCDBZEBGDWSLOO-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinolin-4-amine Chemical compound C1=C2C(N)=CC=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 NCDBZEBGDWSLOO-UHFFFAOYSA-N 0.000 claims description 5
- KJOVAVDYBDKMTQ-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinoline Chemical compound C=1C=C2N=CC=CC2=CC=1C1=CNN=C1C1=CC=CC=N1 KJOVAVDYBDKMTQ-UHFFFAOYSA-N 0.000 claims description 5
- HXELQAJSZOVFHS-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinoxaline Chemical compound C=1C=C2N=CC=NC2=CC=1C1=CNN=C1C1=CC=CC=N1 HXELQAJSZOVFHS-UHFFFAOYSA-N 0.000 claims description 5
- GFFPHAWVDJSDCD-UHFFFAOYSA-N 6-[2-(6-methylpyridin-2-yl)-8-phenylmethoxyimidazo[1,2-a]pyridin-3-yl]-1h-pyrimidin-2-one Chemical compound CC1=CC=CC(C2=C(N3C=CC=C(OCC=4C=CC=CC=4)C3=N2)C=2N=C(O)N=CC=2)=N1 GFFPHAWVDJSDCD-UHFFFAOYSA-N 0.000 claims description 5
- AJJPZAKVXPEORK-UHFFFAOYSA-N 6-[2-tert-butyl-5-(2-cyclopropylpyrimidin-4-yl)-1h-imidazol-4-yl]quinoxaline Chemical compound N1C(C(C)(C)C)=NC(C=2C=C3N=CC=NC3=CC=2)=C1C(N=1)=CC=NC=1C1CC1 AJJPZAKVXPEORK-UHFFFAOYSA-N 0.000 claims description 5
- NVGAONDYQPIKIE-UHFFFAOYSA-N 6-[2-tert-butyl-5-[2-(trifluoromethyl)pyrimidin-4-yl]-1h-imidazol-4-yl]quinoxaline Chemical compound N1C(C(C)(C)C)=NC(C=2C=C3N=CC=NC3=CC=2)=C1C1=CC=NC(C(F)(F)F)=N1 NVGAONDYQPIKIE-UHFFFAOYSA-N 0.000 claims description 5
- LOIUEFXYTURTON-UHFFFAOYSA-N 6-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]-3-fluoro-2-methylpyridine Chemical compound C1=C(F)C(C)=NC(C=2C(=CNN=2)C=2C=C3OCOC3=CC=2)=C1 LOIUEFXYTURTON-UHFFFAOYSA-N 0.000 claims description 5
- HXPKXMCWVLCKKR-UHFFFAOYSA-N 6-[5-(2-cyclopropylpyrimidin-4-yl)-1h-pyrazol-4-yl]quinoxaline Chemical compound C1CC1C1=NC=CC(C=2C(=CNN=2)C=2C=C3N=CC=NC3=CC=2)=N1 HXPKXMCWVLCKKR-UHFFFAOYSA-N 0.000 claims description 5
- POIZGYYUTOZRCK-UHFFFAOYSA-N 6-[5-(2-methylpyrimidin-4-yl)-1h-pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1=NC=CC(C=2C(=CNN=2)C2=CN3N=CN=C3C=C2)=N1 POIZGYYUTOZRCK-UHFFFAOYSA-N 0.000 claims description 5
- JVQZAMYOXIUYDL-UHFFFAOYSA-N 6-[5-(2-methylpyrimidin-4-yl)-1h-pyrazol-4-yl]quinoxaline Chemical compound CC1=NC=CC(C=2C(=CNN=2)C=2C=C3N=CC=NC3=CC=2)=N1 JVQZAMYOXIUYDL-UHFFFAOYSA-N 0.000 claims description 5
- OYIXBSCQTFDIDY-UHFFFAOYSA-N 6-[5-(5-fluoro-6-methylpyridin-2-yl)-1h-pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=C(F)C(C)=NC(C=2C(=CNN=2)C2=CN3N=CN=C3C=C2)=C1 OYIXBSCQTFDIDY-UHFFFAOYSA-N 0.000 claims description 5
- AJBMLLWCODHONW-UHFFFAOYSA-N 6-[5-(5-fluoro-6-methylpyridin-2-yl)-1h-pyrazol-4-yl]quinoxaline Chemical compound C1=C(F)C(C)=NC(C=2C(=CNN=2)C=2C=C3N=CC=NC3=CC=2)=C1 AJBMLLWCODHONW-UHFFFAOYSA-N 0.000 claims description 5
- BFIQDZUMNILOGK-UHFFFAOYSA-N 6-[5-(6-cyclopropylpyridin-2-yl)-1h-pyrazol-4-yl]-3-methylquinazolin-4-one Chemical compound C1=C2C(=O)N(C)C=NC2=CC=C1C1=CNN=C1C(N=1)=CC=CC=1C1CC1 BFIQDZUMNILOGK-UHFFFAOYSA-N 0.000 claims description 5
- WUMVANOOSVNYKD-UHFFFAOYSA-N 6-[5-(6-cyclopropylpyridin-2-yl)-1h-pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1CC1C1=CC=CC(C=2C(=CNN=2)C2=CN3N=CN=C3C=C2)=N1 WUMVANOOSVNYKD-UHFFFAOYSA-N 0.000 claims description 5
- JFQVCSRWSJYYIF-UHFFFAOYSA-N 6-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1=CC=CC(C=2C(=CNN=2)C2=CN3N=CN=C3C=C2)=N1 JFQVCSRWSJYYIF-UHFFFAOYSA-N 0.000 claims description 5
- DIOBLZDPEAWPAK-UHFFFAOYSA-N 6-[5-[2-(trifluoromethyl)pyrimidin-4-yl]-1h-imidazol-4-yl]quinoxaline Chemical compound FC(F)(F)C1=NC=CC(C2=C(N=CN2)C=2C=C3N=CC=NC3=CC=2)=N1 DIOBLZDPEAWPAK-UHFFFAOYSA-N 0.000 claims description 5
- DFKZSZHEFCBQMA-UHFFFAOYSA-N 6-[5-[2-(trifluoromethyl)pyrimidin-4-yl]-1h-pyrazol-4-yl]quinoline Chemical compound FC(F)(F)C1=NC=CC(C=2C(=CNN=2)C=2C=C3C=CC=NC3=CC=2)=N1 DFKZSZHEFCBQMA-UHFFFAOYSA-N 0.000 claims description 5
- QUCZEFSJZSWDGT-UHFFFAOYSA-N 6-[5-[2-(trifluoromethyl)pyrimidin-4-yl]-1h-pyrazol-4-yl]quinoxaline Chemical compound FC(F)(F)C1=NC=CC(C=2C(=CNN=2)C=2C=C3N=CC=NC3=CC=2)=N1 QUCZEFSJZSWDGT-UHFFFAOYSA-N 0.000 claims description 5
- MUFGZCZAWNVPKB-UHFFFAOYSA-N 6-[5-[6-(trifluoromethyl)pyridin-2-yl]-1h-pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=CC=CC(C=2C(=CNN=2)C2=CN3N=CN=C3C=C2)=N1 MUFGZCZAWNVPKB-UHFFFAOYSA-N 0.000 claims description 5
- QHUKINXJUFTAHF-UHFFFAOYSA-N 6-[5-[6-(trifluoromethyl)pyridin-2-yl]-1h-pyrazol-4-yl]quinoxaline Chemical compound FC(F)(F)C1=CC=CC(C=2C(=CNN=2)C=2C=C3N=CC=NC3=CC=2)=N1 QHUKINXJUFTAHF-UHFFFAOYSA-N 0.000 claims description 5
- SKOKDMSZJTZWIE-UHFFFAOYSA-N 6-[6-methyl-2-(6-methylpyridin-2-yl)-8-(2-morpholin-4-ylethylamino)imidazo[1,2-a]pyridin-3-yl]-1h-pyrimidin-2-one Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(O)N=CC=3)N2C=C(C)C=C1NCCN1CCOCC1 SKOKDMSZJTZWIE-UHFFFAOYSA-N 0.000 claims description 5
- RFTKOKDCBIDQNA-UHFFFAOYSA-N 6-[6-methyl-2-(6-methylpyridin-2-yl)-8-(2-pyridin-2-ylethylamino)imidazo[1,2-a]pyridin-3-yl]-1h-pyrimidin-2-one Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(O)N=CC=3)N2C=C(C)C=C1NCCC1=CC=CC=N1 RFTKOKDCBIDQNA-UHFFFAOYSA-N 0.000 claims description 5
- OGXNGNBWPQBARQ-UHFFFAOYSA-N 6-[6-methyl-2-(6-methylpyridin-2-yl)-8-morpholin-4-ylimidazo[1,2-a]pyridin-3-yl]-1h-pyrimidin-2-one Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(O)N=CC=3)N2C=C(C)C=C1N1CCOCC1 OGXNGNBWPQBARQ-UHFFFAOYSA-N 0.000 claims description 5
- SWIZVVDXYOFXQN-UHFFFAOYSA-N 6-bromo-2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CSC1=NC=CC(C=2N3C=C(Br)C=CC3=NC=2C=2N=C(C)C=CC=2)=N1 SWIZVVDXYOFXQN-UHFFFAOYSA-N 0.000 claims description 5
- AJMLNEQOTGDRNA-UHFFFAOYSA-N 7-(5-pyridin-2-yl-1H-pyrazol-4-yl)-[1,2,4]triazolo[1,5-a]pyridine Chemical compound C1=CN2N=CN=C2C=C1C1=CNN=C1C1=CC=CC=N1 AJMLNEQOTGDRNA-UHFFFAOYSA-N 0.000 claims description 5
- ICXIUJASSXTVBC-UHFFFAOYSA-N 7-(5-pyridin-2-yl-1h-pyrazol-4-yl)pyrido[1,2-a]pyrimidin-4-one Chemical compound C=1N2C(=O)C=CN=C2C=CC=1C1=CNN=C1C1=CC=CC=N1 ICXIUJASSXTVBC-UHFFFAOYSA-N 0.000 claims description 5
- NQBCWRKGPJEXOO-UHFFFAOYSA-N 7-[5-[2-(trifluoromethyl)pyrimidin-4-yl]-1H-pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=NC=CC(C=2C(=CNN=2)C2=CC3=NC=NN3C=C2)=N1 NQBCWRKGPJEXOO-UHFFFAOYSA-N 0.000 claims description 5
- BJQWTQKNTPVPHU-UHFFFAOYSA-N 7-amino-4-methyl-3-[2-[4-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]butylamino]-2-oxoethyl]-2-oxochromene-6-sulfonic acid Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCCNC(=O)CC=3C(OC4=CC(N)=C(C=C4C=3C)S(O)(=O)=O)=O)N=CC=2)=N1 BJQWTQKNTPVPHU-UHFFFAOYSA-N 0.000 claims description 5
- YCKNLPTUQULAHN-UHFFFAOYSA-N 7-methoxy-3-methyl-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-one Chemical compound COC1=CC=2N=CN(C)C(=O)C=2C=C1C1=CNN=C1C1=CC=CC=N1 YCKNLPTUQULAHN-UHFFFAOYSA-N 0.000 claims description 5
- FQPQPRZYKJLJIA-UHFFFAOYSA-N 7-methyl-2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound N1=C2C=C(C)C=CN2C(C=2N=C(N=CC=2)S(C)(=O)=O)=C1C1=CC=CC(C)=N1 FQPQPRZYKJLJIA-UHFFFAOYSA-N 0.000 claims description 5
- VTCFAEGIUJRJNF-UHFFFAOYSA-N 8-methyl-2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=CC=C(C)C3=N2)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 VTCFAEGIUJRJNF-UHFFFAOYSA-N 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 5
- XPCUDTLFGOVKAW-UHFFFAOYSA-N [1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl] sulfamate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)OS(N)(=O)=O)C=2C=C3OCOC3=CC=2)=N1 XPCUDTLFGOVKAW-UHFFFAOYSA-N 0.000 claims description 5
- XECULGSXZDNXJQ-UHFFFAOYSA-N [2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyridin-6-yl]methanol Chemical compound CSC1=NC=CC(C=2N3C=C(CO)C=CC3=NC=2C=2N=C(C)C=CC=2)=N1 XECULGSXZDNXJQ-UHFFFAOYSA-N 0.000 claims description 5
- JTTAWSWSUAVCDG-UHFFFAOYSA-N [2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridin-6-yl]methanol Chemical compound CC1=CC=CC(C2=C(N3C=C(CO)C=CC3=N2)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 JTTAWSWSUAVCDG-UHFFFAOYSA-N 0.000 claims description 5
- QEQJSRLUCZMVDY-UHFFFAOYSA-N [3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-6-yl]methanol Chemical compound CC1=CC=CC(C2=C(N3C=C(CO)C=CC3=N2)C=2N=C(N)N=CC=2)=N1 QEQJSRLUCZMVDY-UHFFFAOYSA-N 0.000 claims description 5
- ANTKYHGNIZRNTI-UHFFFAOYSA-N [3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-7-yl]methanol Chemical compound CC1=CC=CC(C2=C(N3C=CC(CO)=CC3=N2)C=2N=C(N)N=CC=2)=N1 ANTKYHGNIZRNTI-UHFFFAOYSA-N 0.000 claims description 5
- BYAKYGFYMNEJPP-UHFFFAOYSA-N [4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]methanol Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CO)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 BYAKYGFYMNEJPP-UHFFFAOYSA-N 0.000 claims description 5
- XOJFPKUVNZNOGI-UHFFFAOYSA-N [4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]methyl methanesulfonate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(COS(C)(=O)=O)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 XOJFPKUVNZNOGI-UHFFFAOYSA-N 0.000 claims description 5
- XLRLGDAZZOAPBN-UHFFFAOYSA-N [4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidin-1-yl]-(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=C(C)C=CC=2)CC1 XLRLGDAZZOAPBN-UHFFFAOYSA-N 0.000 claims description 5
- IAJVXOFFUNWYCJ-UHFFFAOYSA-N [4-[5-(2-cyclopropylpyrimidin-4-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]methanol Chemical compound C1CC(CO)(CC2)CCC12C(N1)=NC(C=2C=C3N=CC=NC3=CC=2)=C1C(N=1)=CC=NC=1C1CC1 IAJVXOFFUNWYCJ-UHFFFAOYSA-N 0.000 claims description 5
- SZPWXAOBLNYOHY-UHFFFAOYSA-N [C]1=CC=NC2=CC=CC=C12 Chemical group [C]1=CC=NC2=CC=CC=C12 SZPWXAOBLNYOHY-UHFFFAOYSA-N 0.000 claims description 5
- 125000000732 arylene group Chemical group 0.000 claims description 5
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 5
- FLPVZFWPLBCBPW-UHFFFAOYSA-N benzyl 3-[4-(1,3-benzodioxol-5-yl)-1-hydroxy-5-(6-methylpyridin-2-yl)imidazol-2-yl]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C=2N(C(C3CN(CCC3)C(=O)OCC=3C=CC=CC=3)=NC=2C=2C=C3OCOC3=CC=2)O)=N1 FLPVZFWPLBCBPW-UHFFFAOYSA-N 0.000 claims description 5
- UYVSVOPNRWVWOK-UHFFFAOYSA-N benzyl 3-[4-(1,3-benzodioxol-5-yl)-1-hydroxy-5-(6-methylpyridin-2-yl)imidazol-2-yl]pyrrolidine-1-carboxylate Chemical compound CC1=CC=CC(C=2N(C(C3CN(CC3)C(=O)OCC=3C=CC=CC=3)=NC=2C=2C=C3OCOC3=CC=2)O)=N1 UYVSVOPNRWVWOK-UHFFFAOYSA-N 0.000 claims description 5
- YYAWRRQXTYRTBM-UHFFFAOYSA-N benzyl 3-[4-(1,3-benzodioxol-5-yl)-1-hydroxy-5-pyridin-2-ylimidazol-2-yl]piperidine-1-carboxylate Chemical compound ON1C(C2CN(CCC2)C(=O)OCC=2C=CC=CC=2)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC=N1 YYAWRRQXTYRTBM-UHFFFAOYSA-N 0.000 claims description 5
- WMRUYLMASOAKIX-UHFFFAOYSA-N benzyl 3-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound C1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CN1C(=O)OCC1=CC=CC=C1 WMRUYLMASOAKIX-UHFFFAOYSA-N 0.000 claims description 5
- ILRMCYWSPJJDHC-UHFFFAOYSA-N benzyl 4-[4-(1,3-benzodioxol-5-yl)-1-hydroxy-5-(6-methylpyridin-2-yl)imidazol-2-yl]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C=2N(C(C3CCN(CC3)C(=O)OCC=3C=CC=CC=3)=NC=2C=2C=C3OCOC3=CC=2)O)=N1 ILRMCYWSPJJDHC-UHFFFAOYSA-N 0.000 claims description 5
- MXPBQVSQKIJLBS-UHFFFAOYSA-N benzyl 4-[4-(1,3-benzodioxol-5-yl)-1-methyl-5-(6-methylpyridin-2-yl)imidazol-2-yl]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C=2N(C(C3CCN(CC3)C(=O)OCC=3C=CC=CC=3)=NC=2C=2C=C3OCOC3=CC=2)C)=N1 MXPBQVSQKIJLBS-UHFFFAOYSA-N 0.000 claims description 5
- YDJKFBCGNSHCTN-UHFFFAOYSA-N benzyl 4-[4-(1,3-benzodioxol-5-yl)-5-(6-ethylpyridin-2-yl)-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound CCC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 YDJKFBCGNSHCTN-UHFFFAOYSA-N 0.000 claims description 5
- RCCQRLHHHFFQTG-UHFFFAOYSA-N benzyl 4-[4-(1,3-benzodioxol-5-yl)-5-[6-(trifluoromethyl)pyridin-2-yl]-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound FC(F)(F)C1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 RCCQRLHHHFFQTG-UHFFFAOYSA-N 0.000 claims description 5
- PBPHCFMNDCXBPN-UHFFFAOYSA-N benzyl 4-[5-(1,3-benzodioxol-5-yl)-1-hydroxy-4-(6-methylpyridin-2-yl)imidazol-2-yl]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C2=C(N(O)C(C3CCN(CC3)C(=O)OCC=3C=CC=CC=3)=N2)C=2C=C3OCOC3=CC=2)=N1 PBPHCFMNDCXBPN-UHFFFAOYSA-N 0.000 claims description 5
- ZEMXQOXSUMNQJR-UHFFFAOYSA-N benzyl 4-[5-(1,3-benzodioxol-5-yl)-1-methyl-4-(6-methylpyridin-2-yl)imidazol-2-yl]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C2=C(N(C)C(C3CCN(CC3)C(=O)OCC=3C=CC=CC=3)=N2)C=2C=C3OCOC3=CC=2)=N1 ZEMXQOXSUMNQJR-UHFFFAOYSA-N 0.000 claims description 5
- FGLYBAMPQJQWRN-UHFFFAOYSA-N benzyl 4-[5-(1,3-benzodioxol-5-yl)-4-(6-bromopyridin-2-yl)-1-hydroxyimidazol-2-yl]piperidine-1-carboxylate Chemical compound C=1C=C2OCOC2=CC=1C=1N(O)C(C2CCN(CC2)C(=O)OCC=2C=CC=CC=2)=NC=1C1=CC=CC(Br)=N1 FGLYBAMPQJQWRN-UHFFFAOYSA-N 0.000 claims description 5
- AYBAYRSDQLKGBA-UHFFFAOYSA-N benzyl 4-[5-(2-cyclopropylpyrimidin-4-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3N=CC=NC3=CC=2)C=2N=C(N=CC=2)C2CC2)CCN1C(=O)OCC1=CC=CC=C1 AYBAYRSDQLKGBA-UHFFFAOYSA-N 0.000 claims description 5
- KYTOWRQDSUTQEP-UHFFFAOYSA-N benzyl n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]carbamate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NC(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 KYTOWRQDSUTQEP-UHFFFAOYSA-N 0.000 claims description 5
- HGVJKJTWVKWHNL-UHFFFAOYSA-N benzyl n-[1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]carbamate Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)NC(=O)OCC=2C=CC=CC=2)C=2N=C(NC3CC3)N=CC=2)=N1 HGVJKJTWVKWHNL-UHFFFAOYSA-N 0.000 claims description 5
- NUNPIJGMCBURAP-UHFFFAOYSA-N benzyl n-[4-[4-(1,3-benzodioxol-5-yl)-1-hydroxy-5-(6-methylpyridin-2-yl)imidazol-2-yl]cyclohexyl]carbamate Chemical compound CC1=CC=CC(C=2N(C(C3CCC(CC3)NC(=O)OCC=3C=CC=CC=3)=NC=2C=2C=C3OCOC3=CC=2)O)=N1 NUNPIJGMCBURAP-UHFFFAOYSA-N 0.000 claims description 5
- HKDZSCRAUDDTJO-UHFFFAOYSA-N benzyl n-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]carbamate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CC2)NC(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 HKDZSCRAUDDTJO-UHFFFAOYSA-N 0.000 claims description 5
- BFSIPABIKNTDAL-UHFFFAOYSA-N benzyl n-[4-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]cyclohexyl]carbamate Chemical compound CC1=CC=CC(C2=C(NC(=N2)C2CCC(CC2)NC(=O)OCC=2C=CC=CC=2)C=2C=C3N=CC=NC3=CC=2)=N1 BFSIPABIKNTDAL-UHFFFAOYSA-N 0.000 claims description 5
- NTKOFBLZGJHQLV-UHFFFAOYSA-N benzyl n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]carbamate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CNC(=O)OCC=3C=CC=CC=3)CC2)C=2C=C3OCOC3=CC=2)=N1 NTKOFBLZGJHQLV-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 125000005724 cycloalkenylene group Chemical group 0.000 claims description 5
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims description 5
- 125000002993 cycloalkylene group Chemical group 0.000 claims description 5
- QFHMDQXPBKJJRC-UHFFFAOYSA-N ethyl 2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyridine-7-carboxylate Chemical compound N1=C2C=C(C(=O)OCC)C=CN2C(C=2N=C(SC)N=CC=2)=C1C1=CC=CC(C)=N1 QFHMDQXPBKJJRC-UHFFFAOYSA-N 0.000 claims description 5
- MLLZUQFQTCAQEX-UHFFFAOYSA-N ethyl 2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridine-7-carboxylate Chemical compound N1=C2C=C(C(=O)OCC)C=CN2C(C=2N=C(N=CC=2)S(C)(=O)=O)=C1C1=CC=CC(C)=N1 MLLZUQFQTCAQEX-UHFFFAOYSA-N 0.000 claims description 5
- UDYZIFHYNMPZCV-UHFFFAOYSA-N ethyl 2-[[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]methyl]cyclopropane-1-carboxylate Chemical compound CCOC(=O)C1CC1CN1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 UDYZIFHYNMPZCV-UHFFFAOYSA-N 0.000 claims description 5
- IGVJTFHMBDHFBX-UHFFFAOYSA-N ethyl 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxylate Chemical compound N1=C2C=C(C(=O)OCC)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 IGVJTFHMBDHFBX-UHFFFAOYSA-N 0.000 claims description 5
- 125000005549 heteroarylene group Chemical group 0.000 claims description 5
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims description 5
- 125000005946 imidazo[1,2-a]pyridyl group Chemical group 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- MUIPEBFNXITVRC-UHFFFAOYSA-N methyl 1-[4-(1,3-benzodioxol-5-yl)-1-hydroxy-5-(6-methylpyridin-2-yl)imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1O)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 MUIPEBFNXITVRC-UHFFFAOYSA-N 0.000 claims description 5
- MLNIHAZFATZMLC-UHFFFAOYSA-N methyl 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 MLNIHAZFATZMLC-UHFFFAOYSA-N 0.000 claims description 5
- YNWJWINZGPMSOV-UHFFFAOYSA-N methyl 1-[4-(3-methyl-4-oxoquinazolin-6-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(NC=1C=2C=C3C(=O)N(C)C=NC3=CC=2)=NC=1C1=CC=CC(C)=N1 YNWJWINZGPMSOV-UHFFFAOYSA-N 0.000 claims description 5
- SHEAUYBYKARAME-UHFFFAOYSA-N methyl 1-[4-(6-methylpyridin-2-yl)-5-(2-methylsulfonylpyrimidin-4-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1)=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(S(C)(=O)=O)=N1 SHEAUYBYKARAME-UHFFFAOYSA-N 0.000 claims description 5
- JPUNLPDLHYEFHG-UHFFFAOYSA-N methyl 1-[4-(6-methylpyridin-2-yl)-5-(2-oxo-1h-pyrimidin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1)=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(=O)N1 JPUNLPDLHYEFHG-UHFFFAOYSA-N 0.000 claims description 5
- VGUBUAAMYIJYSJ-UHFFFAOYSA-N methyl 1-[5-(2-methoxypyrimidin-4-yl)-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1)=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(OC)=N1 VGUBUAAMYIJYSJ-UHFFFAOYSA-N 0.000 claims description 5
- QRNGIZIVLZGQPW-UHFFFAOYSA-N methyl 1-[5-(2-methylpyrimidin-4-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1)=NC(C2=CN3N=CN=C3C=C2)=C1C1=CC=NC(C)=N1 QRNGIZIVLZGQPW-UHFFFAOYSA-N 0.000 claims description 5
- VDOQHHCXPVJPQV-UHFFFAOYSA-N methyl 1-[5-(5-fluoro-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(NC=1C2=CN3N=CN=C3C=C2)=NC=1C1=CC=C(F)C(C)=N1 VDOQHHCXPVJPQV-UHFFFAOYSA-N 0.000 claims description 5
- NWFVHIKWHVMBEH-UHFFFAOYSA-N methyl 1-[5-(6-cyclopropylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(NC=1C2=CN3N=CN=C3C=C2)=NC=1C(N=1)=CC=CC=1C1CC1 NWFVHIKWHVMBEH-UHFFFAOYSA-N 0.000 claims description 5
- FDJOWQXTDJWMPC-UHFFFAOYSA-N methyl 1-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(NC=1C=2C=C3N=CC=NC3=CC=2)=NC=1C1=CC=CC(C)=N1 FDJOWQXTDJWMPC-UHFFFAOYSA-N 0.000 claims description 5
- BONOOAYCHZZVND-UHFFFAOYSA-N methyl 1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1)=NC(C=2N=C(C)C=CC=2)=C1C(N=1)=CC=NC=1NC1CC1 BONOOAYCHZZVND-UHFFFAOYSA-N 0.000 claims description 5
- HUFJMAZLBLCKBL-UHFFFAOYSA-N methyl 2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyridine-6-carboxylate Chemical compound N12C=C(C(=O)OC)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(SC)=N1 HUFJMAZLBLCKBL-UHFFFAOYSA-N 0.000 claims description 5
- PGCUQJWVGDBCCN-UHFFFAOYSA-N methyl 2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridine-6-carboxylate Chemical compound N12C=C(C(=O)OC)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(S(C)(=O)=O)=N1 PGCUQJWVGDBCCN-UHFFFAOYSA-N 0.000 claims description 5
- VVALHDDBBJJYDI-UHFFFAOYSA-N methyl 3-[[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carbonyl]amino]propanoate Chemical compound N12C=C(C(=O)NCCC(=O)OC)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(N)=N1 VVALHDDBBJJYDI-UHFFFAOYSA-N 0.000 claims description 5
- WSIRNNCRNKOMOB-UHFFFAOYSA-N methyl 3-[[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carbonyl]amino]propanoate Chemical compound N1=C2C=C(C(=O)NCCC(=O)OC)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 WSIRNNCRNKOMOB-UHFFFAOYSA-N 0.000 claims description 5
- ZVTWQRWEZQTOQF-UHFFFAOYSA-N methyl 4-[2-[2-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]ethoxy]ethoxy]bicyclo[2.2.2]octane-1-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12OCCOCCN(N=1)C=C(C=2C=C3OCOC3=CC=2)C=1C1=CC=CC(C)=N1 ZVTWQRWEZQTOQF-UHFFFAOYSA-N 0.000 claims description 5
- VCQMZOLWWYQBIZ-UHFFFAOYSA-N methyl 4-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]bicyclo[2.2.2]octane-1-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12N(N=1)C=C(C=2C=C3OCOC3=CC=2)C=1C1=CC=CC(C)=N1 VCQMZOLWWYQBIZ-UHFFFAOYSA-N 0.000 claims description 5
- SKUDIQGDJCJNBP-UHFFFAOYSA-N n',n'-dimethyl-n-[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]ethane-1,2-diamine Chemical compound CN(C)CCNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 SKUDIQGDJCJNBP-UHFFFAOYSA-N 0.000 claims description 5
- PLPJZUFRCQISJL-UHFFFAOYSA-N n,n-dimethyl-3-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)propan-1-amine Chemical compound N=1N(CCCN(C)C)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 PLPJZUFRCQISJL-UHFFFAOYSA-N 0.000 claims description 5
- LHBQJBASKOAGGW-UHFFFAOYSA-N n,n-dimethyl-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CN(C)C1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 LHBQJBASKOAGGW-UHFFFAOYSA-N 0.000 claims description 5
- NSXRXTQIPOLKAQ-UHFFFAOYSA-N n,n-dimethyl-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazole-3-carboxamide Chemical compound C1=C2C(C(=O)N(C)C)=NNC2=CC=C1C1=CNN=C1C1=CC=CC=N1 NSXRXTQIPOLKAQ-UHFFFAOYSA-N 0.000 claims description 5
- ATZVYFZDGMLQDL-UHFFFAOYSA-N n-(1h-benzimidazol-2-yl)-1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NC=2NC3=CC=CC=C3N=2)C=2C=C3OCOC3=CC=2)=N1 ATZVYFZDGMLQDL-UHFFFAOYSA-N 0.000 claims description 5
- JADDVONWNKKVFF-UHFFFAOYSA-N n-(2,2-dimethylpropyl)-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazole-3-carboxamide Chemical compound C1=C2C(C(=O)NCC(C)(C)C)=NNC2=CC=C1C=1C=NNC=1C1=CC=CC=N1 JADDVONWNKKVFF-UHFFFAOYSA-N 0.000 claims description 5
- WWSCCUJUUTZBPL-UHFFFAOYSA-N n-(2-methoxyethyl)-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound COCCNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 WWSCCUJUUTZBPL-UHFFFAOYSA-N 0.000 claims description 5
- IMZHFBNWTRKGPJ-UHFFFAOYSA-N n-(3-imidazol-1-ylpropyl)-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCN3C=NC=C3)N=CC=2)=N1 IMZHFBNWTRKGPJ-UHFFFAOYSA-N 0.000 claims description 5
- PCCDINVHZJGVQS-UHFFFAOYSA-N n-(4-morpholin-4-ylphenyl)-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-amine Chemical compound C1COCCN1C(C=C1)=CC=C1NC1=NC=NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C12 PCCDINVHZJGVQS-UHFFFAOYSA-N 0.000 claims description 5
- RQLBSRWECGGUKO-UHFFFAOYSA-N n-[(4-aminophenyl)methyl]-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCC=3C=CC(N)=CC=3)N=CC=2)=N1 RQLBSRWECGGUKO-UHFFFAOYSA-N 0.000 claims description 5
- LZZKVZNLUYDCJN-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]-1-methylimidazole-4-sulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(=O)(=O)C=2N=CN(C)C=2)C=2C=C3OCOC3=CC=2)=N1 LZZKVZNLUYDCJN-UHFFFAOYSA-N 0.000 claims description 5
- BNEKNFBLMPBYDD-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]-1-phenylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(=O)(=O)CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 BNEKNFBLMPBYDD-UHFFFAOYSA-N 0.000 claims description 5
- WXIRAUQWCUZUEN-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]-1-pyridin-2-ylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(=O)(=O)CC=2N=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 WXIRAUQWCUZUEN-UHFFFAOYSA-N 0.000 claims description 5
- OCBBSNQNKKGPDP-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]acetamide Chemical compound C1CC(NC(=O)C)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 OCBBSNQNKKGPDP-UHFFFAOYSA-N 0.000 claims description 5
- FZEJDYTUUDDWPT-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(=O)(=O)C=2SC=CC=2)C=2C=C3OCOC3=CC=2)=N1 FZEJDYTUUDDWPT-UHFFFAOYSA-N 0.000 claims description 5
- FLFUCQHZGVBFDA-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]thiophene-3-sulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(=O)(=O)C2=CSC=C2)C=2C=C3OCOC3=CC=2)=N1 FLFUCQHZGVBFDA-UHFFFAOYSA-N 0.000 claims description 5
- XAUGBHAXFOOAIF-UHFFFAOYSA-N n-[1-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]acetamide Chemical compound C1CC(NC(=O)C)(CC2)CCC12C(N1)=NC(C=2C=C3N=CC=NC3=CC=2)=C1C1=CC=CC(C)=N1 XAUGBHAXFOOAIF-UHFFFAOYSA-N 0.000 claims description 5
- CPXWHQHMPSLSIT-UHFFFAOYSA-N n-[1-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]methanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(C)(=O)=O)C=2C=C3N=CC=NC3=CC=2)=N1 CPXWHQHMPSLSIT-UHFFFAOYSA-N 0.000 claims description 5
- CIJIVQDXYSUZPF-UHFFFAOYSA-N n-[2-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)ethyl]methanesulfonamide Chemical compound N=1N(CCNS(=O)(=O)C)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 CIJIVQDXYSUZPF-UHFFFAOYSA-N 0.000 claims description 5
- IHMOMVMNTVXNDN-UHFFFAOYSA-N n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]-3-pyridin-3-ylpropanamide Chemical compound CSC1=NC=CC(C=2N3C=CC(NC(=O)CCC=4C=NC=CC=4)=NC3=NC=2C=2N=C(C)C=CC=2)=N1 IHMOMVMNTVXNDN-UHFFFAOYSA-N 0.000 claims description 5
- WEVPRMMAVXDFRH-UHFFFAOYSA-N n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]propanamide Chemical compound N1=C2N=C(NC(=O)CC)C=CN2C(C=2N=C(N=CC=2)S(C)(=O)=O)=C1C1=CC=CC(C)=N1 WEVPRMMAVXDFRH-UHFFFAOYSA-N 0.000 claims description 5
- UVHPZRONHYJPKH-UHFFFAOYSA-N n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]pyridine-3-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(NC(=O)C=4C=NC=CC=4)=NC3=N2)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 UVHPZRONHYJPKH-UHFFFAOYSA-N 0.000 claims description 5
- YYAVSZGFEPUTHP-UHFFFAOYSA-N n-[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidin-7-yl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NC2=NC3=NC(=C(N3C=C2)C=2N=C(N)N=CC=2)C=2N=C(C)C=CC=2)=C1 YYAVSZGFEPUTHP-UHFFFAOYSA-N 0.000 claims description 5
- JDBVSUUJSFDFFW-UHFFFAOYSA-N n-[3-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)propyl]acetamide Chemical compound N=1N(CCCNC(=O)C)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 JDBVSUUJSFDFFW-UHFFFAOYSA-N 0.000 claims description 5
- UFFLRNPZBQSJLA-UHFFFAOYSA-N n-[3-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)propyl]methanesulfonamide Chemical compound N=1N(CCCNS(=O)(=O)C)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 UFFLRNPZBQSJLA-UHFFFAOYSA-N 0.000 claims description 5
- MCXIJRXEPGHSNX-UHFFFAOYSA-N n-[3-(4-methylpiperazin-1-yl)propyl]-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1CN(C)CCN1CCCNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 MCXIJRXEPGHSNX-UHFFFAOYSA-N 0.000 claims description 5
- JYJCLZJDOYHSJZ-UHFFFAOYSA-N n-[3-(4-methylpiperidin-1-yl)propyl]-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1CC(C)CCN1CCCNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 JYJCLZJDOYHSJZ-UHFFFAOYSA-N 0.000 claims description 5
- YLONOLZALBGKKB-UHFFFAOYSA-N n-[3-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]propyl]methanesulfonamide Chemical compound CC1=CC=CC(C=2C(=CN(CCCNS(C)(=O)=O)N=2)C=2C=C3OCOC3=CC=2)=N1 YLONOLZALBGKKB-UHFFFAOYSA-N 0.000 claims description 5
- WZEQZQOEXMACDP-UHFFFAOYSA-N n-[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]-1,3,4-thiadiazol-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NC=3SC=NN=3)N=CC=2)=N1 WZEQZQOEXMACDP-UHFFFAOYSA-N 0.000 claims description 5
- YQTXBCQGMQIFHA-UHFFFAOYSA-N n-[4-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]cyclohexyl]methanesulfonamide Chemical compound CC1=CC=CC(C=2C(=CN(N=2)C2CCC(CC2)NS(C)(=O)=O)C=2C=C3OCOC3=CC=2)=N1 YQTXBCQGMQIFHA-UHFFFAOYSA-N 0.000 claims description 5
- VZLCIGZSUBXKFU-UHFFFAOYSA-N n-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]-1-methylimidazole-4-sulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CC2)NS(=O)(=O)C=2N=CN(C)C=2)C=2C=C3OCOC3=CC=2)=N1 VZLCIGZSUBXKFU-UHFFFAOYSA-N 0.000 claims description 5
- BNRHAYBJQHUPFO-UHFFFAOYSA-N n-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]butane-1-sulfonamide Chemical compound C1CC(NS(=O)(=O)CCCC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 BNRHAYBJQHUPFO-UHFFFAOYSA-N 0.000 claims description 5
- SQAMQHSJXJSQPS-UHFFFAOYSA-N n-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]thiophene-2-sulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CC2)NS(=O)(=O)C=2SC=CC=2)C=2C=C3OCOC3=CC=2)=N1 SQAMQHSJXJSQPS-UHFFFAOYSA-N 0.000 claims description 5
- SSOWKIPDUUSTQR-UHFFFAOYSA-N n-[4-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]cyclohexyl]methanesulfonamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C2CCC(CC2)NS(C)(=O)=O)C=2C=C3N=CC=NC3=CC=2)=N1 SSOWKIPDUUSTQR-UHFFFAOYSA-N 0.000 claims description 5
- COZHHCCXEPKUPS-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]methyl]-1-phenylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CNS(=O)(=O)CC=4C=CC=CC=4)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 COZHHCCXEPKUPS-UHFFFAOYSA-N 0.000 claims description 5
- HLEPPLCYOPROMT-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]-1-phenylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CNS(=O)(=O)CC=3C=CC=CC=3)CC2)C=2C=C3OCOC3=CC=2)=N1 HLEPPLCYOPROMT-UHFFFAOYSA-N 0.000 claims description 5
- ILVOUIRNTYMOBH-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]-1-pyridin-2-ylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CNS(=O)(=O)CC=3N=CC=CC=3)CC2)C=2C=C3OCOC3=CC=2)=N1 ILVOUIRNTYMOBH-UHFFFAOYSA-N 0.000 claims description 5
- KAYVCFMKCMLIDK-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]-1-pyridin-4-ylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CNS(=O)(=O)CC=3C=CN=CC=3)CC2)C=2C=C3OCOC3=CC=2)=N1 KAYVCFMKCMLIDK-UHFFFAOYSA-N 0.000 claims description 5
- OGDDSGBJTFBANP-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]acetamide Chemical compound C1CC(CNC(=O)C)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 OGDDSGBJTFBANP-UHFFFAOYSA-N 0.000 claims description 5
- YPDUTSPYVABKFP-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]methanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CNS(C)(=O)=O)CC2)C=2C=C3OCOC3=CC=2)=N1 YPDUTSPYVABKFP-UHFFFAOYSA-N 0.000 claims description 5
- HQUAVNGZXPDBGG-UHFFFAOYSA-N n-benzyl-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazole-3-carboxamide Chemical compound N=1NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C2C=1C(=O)NCC1=CC=CC=C1 HQUAVNGZXPDBGG-UHFFFAOYSA-N 0.000 claims description 5
- XNAAOIBANVQHDR-UHFFFAOYSA-N n-cyclopentyl-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NC3CCCC3)N=CC=2)=N1 XNAAOIBANVQHDR-UHFFFAOYSA-N 0.000 claims description 5
- BOZKLPKKXYBXKP-UHFFFAOYSA-N n-cyclopropyl-n-methyl-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound N=1C=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=NC=1N(C)C1CC1 BOZKLPKKXYBXKP-UHFFFAOYSA-N 0.000 claims description 5
- HPDIJGLJVPCQPX-UHFFFAOYSA-N n-hydroxy-1-[5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(=O)NO)C2=CN3N=CN=C3C=C2)=N1 HPDIJGLJVPCQPX-UHFFFAOYSA-N 0.000 claims description 5
- SJVMSBCSXJCECY-UHFFFAOYSA-N n-hydroxy-1-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(=O)NO)C=2C=C3N=CC=NC3=CC=2)=N1 SJVMSBCSXJCECY-UHFFFAOYSA-N 0.000 claims description 5
- TVGHQAZJZCDHCM-UHFFFAOYSA-N n-hydroxy-3-(3-pyridin-2-yl-4-quinolin-4-ylpyrazol-1-yl)propanamide Chemical compound N=1N(CCC(=O)NO)C=C(C=2C3=CC=CC=C3N=CC=2)C=1C1=CC=CC=N1 TVGHQAZJZCDHCM-UHFFFAOYSA-N 0.000 claims description 5
- RRRGHOSHLCPQLU-UHFFFAOYSA-N n-methyl-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 RRRGHOSHLCPQLU-UHFFFAOYSA-N 0.000 claims description 5
- QMDPZBJUHORZHH-UHFFFAOYSA-N n-methyl-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazole-3-carboxamide Chemical compound C1=C2C(C(=O)NC)=NNC2=CC=C1C1=CNN=C1C1=CC=CC=N1 QMDPZBJUHORZHH-UHFFFAOYSA-N 0.000 claims description 5
- VGXNKFNLPSVFAI-UHFFFAOYSA-N n-phenyl-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazole-3-carboxamide Chemical compound N=1NC2=CC=C(C3=C(NN=C3)C=3N=CC=CC=3)C=C2C=1C(=O)NC1=CC=CC=C1 VGXNKFNLPSVFAI-UHFFFAOYSA-N 0.000 claims description 5
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- ZVKRNQYPRSEQLT-UHFFFAOYSA-N tert-butyl 2-[[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]methyl]pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC1CN1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 ZVKRNQYPRSEQLT-UHFFFAOYSA-N 0.000 claims description 5
- KSGUWWVYVKIXKD-UHFFFAOYSA-N tert-butyl n-[4-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]butyl]carbamate Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCCNC(=O)OC(C)(C)C)N=CC=2)=N1 KSGUWWVYVKIXKD-UHFFFAOYSA-N 0.000 claims description 5
- GJXUUDPBMCBINS-UHFFFAOYSA-N tert-butyl n-[5-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]pentyl]carbamate Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCCCNC(=O)OC(C)(C)C)N=CC=2)=N1 GJXUUDPBMCBINS-UHFFFAOYSA-N 0.000 claims description 5
- 125000000464 thioxo group Chemical group S=* 0.000 claims description 5
- FXPNNBPYKCSUKM-UHFFFAOYSA-N (4-methoxyphenyl)-[6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazolin-4-yl]methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=NC=NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C12 FXPNNBPYKCSUKM-UHFFFAOYSA-N 0.000 claims description 4
- VCCKBRVPZFATNP-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-1-hydroxy-5-(6-methylpyridin-2-yl)imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C=2N(C(=NC=2C=2C=C3OCOC3=CC=2)C23CCC(CC2)(CC3)C(N)=O)O)=N1 VCCKBRVPZFATNP-UHFFFAOYSA-N 0.000 claims description 4
- JJNJCSWAUNUNME-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-cyclohexylbicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NC2CCCCC2)C=2C=C3OCOC3=CC=2)=N1 JJNJCSWAUNUNME-UHFFFAOYSA-N 0.000 claims description 4
- FQKPLAVROJGWCP-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carbohydrazide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NN)C=2C=C3OCOC3=CC=2)=N1 FQKPLAVROJGWCP-UHFFFAOYSA-N 0.000 claims description 4
- MPBWLALQULSSSD-UHFFFAOYSA-N 1-[4-(3-methyl-4-oxoquinazolin-6-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(N)=O)C=2C=C3C(=O)N(C)C=NC3=CC=2)=N1 MPBWLALQULSSSD-UHFFFAOYSA-N 0.000 claims description 4
- ZYTPHJMFJJGFAE-UHFFFAOYSA-N 1-[5-(2-methylpyrimidin-4-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]bicyclo[2.2.2]octan-4-ol Chemical compound CC1=NC=CC(C2=C(N=C(N2)C23CCC(O)(CC2)CC3)C=2C=C3N=CC=NC3=CC=2)=N1 ZYTPHJMFJJGFAE-UHFFFAOYSA-N 0.000 claims description 4
- WJADENHXXXGFQC-UHFFFAOYSA-N 1-[5-(6-cyclopropylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)N)(CC2)CCC12C(NC=1C2=CN3N=CN=C3C=C2)=NC=1C(N=1)=CC=CC=1C1CC1 WJADENHXXXGFQC-UHFFFAOYSA-N 0.000 claims description 4
- SDJBBSCKFMBPRN-UHFFFAOYSA-N 1-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(N)=O)C=2C=C3N=CC=NC3=CC=2)=N1 SDJBBSCKFMBPRN-UHFFFAOYSA-N 0.000 claims description 4
- GIJBVTBOMJGKKK-UHFFFAOYSA-N 2-(3-amino-6-iminoxanthen-9-yl)-4-[4-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]butylcarbamoyl]benzoic acid Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCCNC(=O)C=3C=C(C(C(O)=O)=CC=3)C3=C4C=CC(=N)C=C4OC4=CC(N)=CC=C43)N=CC=2)=N1 GIJBVTBOMJGKKK-UHFFFAOYSA-N 0.000 claims description 4
- SBOQNZCQEFSIBJ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-propylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]pyridine Chemical compound C1CN(S(=O)(=O)CCC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=CC=CC=2)N1 SBOQNZCQEFSIBJ-UHFFFAOYSA-N 0.000 claims description 4
- ZFHPVSVBYUVQQV-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(1-methylimidazol-4-yl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)C=2N=CN(C)C=2)C=2C=C3OCOC3=CC=2)=N1 ZFHPVSVBYUVQQV-UHFFFAOYSA-N 0.000 claims description 4
- JKRBSKGJJHPDKW-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-phenoxyphenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C=1C=C(OC=2C=CC=CC=2)C=CC=1S(=O)(=O)N(CC1)CCC1C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC=N1 JKRBSKGJJHPDKW-UHFFFAOYSA-N 0.000 claims description 4
- VTNZDIXVWUFWCR-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[4-(2h-tetrazol-5-yl)-1-bicyclo[2.2.2]octanyl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C=2NN=NN=2)C=2C=C3OCOC3=CC=2)=N1 VTNZDIXVWUFWCR-UHFFFAOYSA-N 0.000 claims description 4
- UFOODNGHDAVHSP-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-5-(trifluoromethyl)-1h-pyrazol-3-yl]-6-bromopyridine Chemical compound C=1C=C2OCOC2=CC=1C1=C(C(F)(F)F)NN=C1C1=CC=CC(Br)=N1 UFOODNGHDAVHSP-UHFFFAOYSA-N 0.000 claims description 4
- FEBFVHXQOMKXJX-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)-n-(2-thiophen-2-ylethyl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NCCC=2SC=CC=2)C=2N=C(N)N=CC=2)=N1 FEBFVHXQOMKXJX-UHFFFAOYSA-N 0.000 claims description 4
- GRZYOCPOBQZHDY-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-6-methyl-2-(6-methylpyridin-2-yl)-n-(2-morpholin-4-ylethyl)imidazo[1,2-a]pyridin-8-amine Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(N)N=CC=3)N2C=C(C)C=C1NCCN1CCOCC1 GRZYOCPOBQZHDY-UHFFFAOYSA-N 0.000 claims description 4
- YWJXDLAGSVQNRE-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-6-methyl-2-(6-methylpyridin-2-yl)-n-(2-pyridin-3-ylethyl)imidazo[1,2-a]pyridin-8-amine Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(N)N=CC=3)N2C=C(C)C=C1NCCC1=CC=CN=C1 YWJXDLAGSVQNRE-UHFFFAOYSA-N 0.000 claims description 4
- MPPCLPUSEFDPGS-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-(1,4-dioxan-2-ylmethyl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NCC2OCCOC2)C=2N=C(N)N=CC=2)=N1 MPPCLPUSEFDPGS-UHFFFAOYSA-N 0.000 claims description 4
- WSEICPQOLNGCPR-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-8-phenylmethoxyimidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=C(OCC=4C=CC=CC=4)C3=N2)C=2N=C(N)N=CC=2)=N1 WSEICPQOLNGCPR-UHFFFAOYSA-N 0.000 claims description 4
- VENUMYHILKBIGQ-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)pyrazolo[1,5-c]pyrimidin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C=2C(=C3C=CN=CN3N=2)C=2N=C(N)N=CC=2)=N1 VENUMYHILKBIGQ-UHFFFAOYSA-N 0.000 claims description 4
- DPICOUUHHUBYDI-UHFFFAOYSA-N 6-[5-[2-(trifluoromethyl)pyrimidin-4-yl]-1h-pyrazol-4-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound FC(F)(F)C1=NC=CC(C=2C(=CNN=2)C2=CN3N=CN=C3C=C2)=N1 DPICOUUHHUBYDI-UHFFFAOYSA-N 0.000 claims description 4
- 101150101604 ACVR1B gene Proteins 0.000 claims description 4
- BTAJRCJWIJOGDV-UHFFFAOYSA-N [4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidin-1-yl]-(3-chlorophenyl)methanone Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)C=2C=C(Cl)C=CC=2)C=2C=C3OCOC3=CC=2)=N1 BTAJRCJWIJOGDV-UHFFFAOYSA-N 0.000 claims description 4
- YSFRQMGFXGXWMD-UHFFFAOYSA-N methyl 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxylate Chemical compound N12C=C(C(=O)OC)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(N)=N1 YSFRQMGFXGXWMD-UHFFFAOYSA-N 0.000 claims description 4
- XXIVJMVKDFQRIS-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]methanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NS(C)(=O)=O)C=2C=C3OCOC3=CC=2)=N1 XXIVJMVKDFQRIS-UHFFFAOYSA-N 0.000 claims description 4
- OFYLYPTVTMOCTB-UHFFFAOYSA-N n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]propanamide Chemical compound N1=C2N=C(NC(=O)CC)C=CN2C(C=2N=C(SC)N=CC=2)=C1C1=CC=CC(C)=N1 OFYLYPTVTMOCTB-UHFFFAOYSA-N 0.000 claims description 4
- AXAGAGTVHZOYQD-UHFFFAOYSA-N n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]-3-pyridin-3-ylpropanamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(NC(=O)CCC=4C=NC=CC=4)=NC3=N2)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 AXAGAGTVHZOYQD-UHFFFAOYSA-N 0.000 claims description 4
- VGLHRJFHJIIEGB-UHFFFAOYSA-N n-[2-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]ethyl]methanesulfonamide Chemical compound CC1=CC=CC(C=2C(=CN(CCNS(C)(=O)=O)N=2)C=2C=C3OCOC3=CC=2)=N1 VGLHRJFHJIIEGB-UHFFFAOYSA-N 0.000 claims description 4
- VPRBGKHSSMMFKG-UHFFFAOYSA-N n-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]-1-phenylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CC2)NS(=O)(=O)CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 VPRBGKHSSMMFKG-UHFFFAOYSA-N 0.000 claims description 4
- FPVNUKSAQKMDQL-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]butane-1-sulfonamide Chemical compound C1CC(CNS(=O)(=O)CCCC)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 FPVNUKSAQKMDQL-UHFFFAOYSA-N 0.000 claims description 4
- XRQCPLADXMJECN-UHFFFAOYSA-N n-hydroxy-1-[4-(3-methyl-4-oxoquinazolin-6-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NO)C=2C=C3C(=O)N(C)C=NC3=CC=2)=N1 XRQCPLADXMJECN-UHFFFAOYSA-N 0.000 claims description 4
- 229940080818 propionamide Drugs 0.000 claims description 4
- PCCZEQHMOCIYSN-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[[3-(trifluoromethyl)phenyl]methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound FC(F)(F)C1=CC=CC(CS(=O)(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)=C1 PCCZEQHMOCIYSN-UHFFFAOYSA-N 0.000 claims description 3
- WMBVVXOGMONONM-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-[2-(dimethylamino)ethyl]-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound N12C=C(C(=O)NCCN(C)C)C=CC2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(N)=N1 WMBVVXOGMONONM-UHFFFAOYSA-N 0.000 claims description 3
- IIVJQOJFWOXTLG-UHFFFAOYSA-N morpholin-4-yl-[5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazol-3-yl]methanone Chemical compound N=1NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C2C=1C(=O)N1CCOCC1 IIVJQOJFWOXTLG-UHFFFAOYSA-N 0.000 claims description 3
- HNZSKMMZMZQUQM-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]methyl]propane-2-sulfonamide Chemical compound C1CC(CNS(=O)(=O)C(C)C)CCC1C1=NC(C=2C=C3OCOC3=CC=2)=C(C=2N=C(C)C=CC=2)N1 HNZSKMMZMZQUQM-UHFFFAOYSA-N 0.000 claims description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 3
- SBIXZUVKSKBIOQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(pyridin-4-ylmethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=CN=CC=2)C=2C=C3OCOC3=CC=2)=N1 SBIXZUVKSKBIOQ-UHFFFAOYSA-N 0.000 claims description 2
- HVLUYXIJZLDNIS-UHFFFAOYSA-N 2-thiophen-2-ylethanamine Chemical compound NCCC1=CC=CS1 HVLUYXIJZLDNIS-UHFFFAOYSA-N 0.000 claims description 2
- 201000000054 Coronary Restenosis Diseases 0.000 claims description 2
- 206010056489 Coronary artery restenosis Diseases 0.000 claims description 2
- ZXKINMCYCKHYFR-UHFFFAOYSA-N aminooxidanide Chemical compound [O-]N ZXKINMCYCKHYFR-UHFFFAOYSA-N 0.000 claims description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 28
- SVVCBKPGSAZAIZ-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-(1,4-dioxan-2-ylmethyl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C(=O)NCC2OCCOC2)C=2N=C(N)N=CC=2)=N1 SVVCBKPGSAZAIZ-UHFFFAOYSA-N 0.000 claims 8
- VXTGVZRNWICVJF-UHFFFAOYSA-N n-[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidin-7-yl]acetamide Chemical compound N1=C2N=C(NC(=O)C)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 VXTGVZRNWICVJF-UHFFFAOYSA-N 0.000 claims 8
- RGNMSMJXVJXJIK-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(3-imidazol-1-ylpropyl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NCCCN2C=NC=C2)C=2C=C3OCOC3=CC=2)=N1 RGNMSMJXVJXJIK-UHFFFAOYSA-N 0.000 claims 4
- ZRTGIBNKIAKGJK-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-[(3-chloro-4-fluorophenyl)methyl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NCC=2C=C(Cl)C(F)=CC=2)C=2C=C3OCOC3=CC=2)=N1 ZRTGIBNKIAKGJK-UHFFFAOYSA-N 0.000 claims 4
- SXNCKMDMFDMHGZ-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-butylbicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)NCCCC)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 SXNCKMDMFDMHGZ-UHFFFAOYSA-N 0.000 claims 4
- XZZCGMDSLJGNSF-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-ethylbicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)NCC)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 XZZCGMDSLJGNSF-UHFFFAOYSA-N 0.000 claims 4
- HDYXSERXYSWHPR-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-methylbicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)NC)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 HDYXSERXYSWHPR-UHFFFAOYSA-N 0.000 claims 4
- CFAJOGKZNGBSHP-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-propan-2-ylbicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)NC(C)C)(CC2)CCC12C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC(C)=N1 CFAJOGKZNGBSHP-UHFFFAOYSA-N 0.000 claims 4
- XEDYDXQBBLLNLV-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octan-4-ol Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(O)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 XEDYDXQBBLLNLV-UHFFFAOYSA-N 0.000 claims 4
- JUHTXZGCTPDXRU-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(N)=O)C=2C=C3OCOC3=CC=2)=N1 JUHTXZGCTPDXRU-UHFFFAOYSA-N 0.000 claims 4
- LZAPLGQNLFUTOU-UHFFFAOYSA-N 1-[4-quinoxalin-6-yl-5-[2-(trifluoromethyl)pyrimidin-4-yl]-1h-imidazol-2-yl]bicyclo[2.2.2]octan-4-ol Chemical compound C1CC(O)(CC2)CCC12C(N1)=NC(C=2C=C3N=CC=NC3=CC=2)=C1C1=CC=NC(C(F)(F)F)=N1 LZAPLGQNLFUTOU-UHFFFAOYSA-N 0.000 claims 4
- NHBUNMRREKYNKL-UHFFFAOYSA-N 1-[5-(2-cyclopropylpyrimidin-4-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]bicyclo[2.2.2]octan-4-ol Chemical compound C1CC(O)(CC2)CCC12C(N1)=NC(C=2C=C3N=CC=NC3=CC=2)=C1C(N=1)=CC=NC=1C1CC1 NHBUNMRREKYNKL-UHFFFAOYSA-N 0.000 claims 4
- HBTUBFWKPRCCGB-UHFFFAOYSA-N 1-[5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(N)=O)C2=CN3N=CN=C3C=C2)=N1 HBTUBFWKPRCCGB-UHFFFAOYSA-N 0.000 claims 4
- VFTPRXRFTGGRMR-UHFFFAOYSA-N 1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-hydroxybicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(=O)NO)C=2N=C(NC3CC3)N=CC=2)=N1 VFTPRXRFTGGRMR-UHFFFAOYSA-N 0.000 claims 4
- GNHRGEPQRGPMCT-UHFFFAOYSA-N 1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-methoxybicyclo[2.2.2]octane-4-carboxamide Chemical compound C1CC(C(=O)NOC)(CC2)CCC12C(N1)=NC(C=2N=C(C)C=CC=2)=C1C(N=1)=CC=NC=1NC1CC1 GNHRGEPQRGPMCT-UHFFFAOYSA-N 0.000 claims 4
- BFTOGZFVFWSNJF-UHFFFAOYSA-N 1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)C(N)=O)C=2N=C(NC3CC3)N=CC=2)=N1 BFTOGZFVFWSNJF-UHFFFAOYSA-N 0.000 claims 4
- MZJSZQWWQZFBNG-UHFFFAOYSA-N 2,2,2-trifluoro-n-[4-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]cyclohexyl]acetamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C2CCC(CC2)NC(=O)C(F)(F)F)C=2C=C3N=CC=NC3=CC=2)=N1 MZJSZQWWQZFBNG-UHFFFAOYSA-N 0.000 claims 4
- ZXZQBJLOMCZQHF-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2-pyrrolidin-1-ylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(N=CC=2)N2CCCC2)=N1 ZXZQBJLOMCZQHF-UHFFFAOYSA-N 0.000 claims 4
- OYBDBJISEUFIPR-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-1h-pyrazol-5-yl]pyridine Chemical compound C1=C2OCOC2=CC=C1C1=CNN=C1C1=CC=CC=N1 OYBDBJISEUFIPR-UHFFFAOYSA-N 0.000 claims 4
- HXKYYFMLJPHFTP-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-benzylsulfonylpiperidin-3-yl)-1h-imidazol-5-yl]pyridine Chemical compound C1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CN1S(=O)(=O)CC1=CC=CC=C1 HXKYYFMLJPHFTP-UHFFFAOYSA-N 0.000 claims 4
- RDGCFSQXZFOYHX-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-benzylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-ethylpyridine Chemical compound CCC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 RDGCFSQXZFOYHX-UHFFFAOYSA-N 0.000 claims 4
- NLYMASABUDSJAK-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-benzylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1S(=O)(=O)CC1=CC=CC=C1 NLYMASABUDSJAK-UHFFFAOYSA-N 0.000 claims 4
- HGSNZSXZNFRRKD-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(2-phenylethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 HGSNZSXZNFRRKD-UHFFFAOYSA-N 0.000 claims 4
- KXWFPORIVJKXPN-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(4-phenylphenyl)sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1S(=O)(=O)N(CC1)CCC1C(N1)=NC(C=2C=C3OCOC3=CC=2)=C1C1=CC=CC=N1 KXWFPORIVJKXPN-UHFFFAOYSA-N 0.000 claims 4
- JMYMOBAFZUSNHT-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(furan-2-yl)-2-methylpiperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound CC1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1C1=CC=CO1 JMYMOBAFZUSNHT-UHFFFAOYSA-N 0.000 claims 4
- OPLIBFMPIBWMKJ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(pyridin-3-ylmethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1S(=O)(=O)CC1=CC=CN=C1 OPLIBFMPIBWMKJ-UHFFFAOYSA-N 0.000 claims 4
- KWYXWHJTVNXDNG-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-(pyridin-4-ylmethylsulfonyl)piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1S(=O)(=O)CC1=CC=NC=C1 KWYXWHJTVNXDNG-UHFFFAOYSA-N 0.000 claims 4
- GRYJBXNBDAWYNI-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(2-nitrophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C(=CC=CC=2)[N+]([O-])=O)C=2C=C3OCOC3=CC=2)=N1 GRYJBXNBDAWYNI-UHFFFAOYSA-N 0.000 claims 4
- XCFZTCGAQOLULN-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(4-fluorophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(F)=CC=C1CS(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 XCFZTCGAQOLULN-UHFFFAOYSA-N 0.000 claims 4
- CFNZVCJCUGTYBR-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(4-methylphenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1=CC(C)=CC=C1CS(=O)(=O)N1CCC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CC1 CFNZVCJCUGTYBR-UHFFFAOYSA-N 0.000 claims 4
- OVTSOLBWYPDIHT-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(4-phenylphenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1S(=O)(=O)CC(C=C1)=CC=C1C1=CC=CC=C1 OVTSOLBWYPDIHT-UHFFFAOYSA-N 0.000 claims 4
- ATYHAOKWLVQUSW-UHFFFAOYSA-N 2-[4-(2,3-dihydro-1,4-benzodioxin-6-yl)-1h-pyrazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C=2C(=CNN=2)C=2C=C3OCCOC3=CC=2)=N1 ATYHAOKWLVQUSW-UHFFFAOYSA-N 0.000 claims 4
- IHUYHJOWTKRENW-UHFFFAOYSA-N 2-[[4-[4-(1,3-benzodioxol-5-yl)-5-pyridin-2-yl-1h-imidazol-2-yl]piperidin-1-yl]sulfonylmethyl]pyridine Chemical compound C1CC(C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=CC=CC=2)CCN1S(=O)(=O)CC1=CC=CC=N1 IHUYHJOWTKRENW-UHFFFAOYSA-N 0.000 claims 4
- VZJCYHQIJKTKCJ-UHFFFAOYSA-N 3,6-dichloro-4-[4-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]butylcarbamoyl]-2-(2,4,5,7-tetrachloro-3-hydroxy-6-oxo-8a,9-dihydroxanthen-9-yl)benzoic acid Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCCNC(=O)C=3C(=C(C4C5=CC(Cl)=C(O)C(Cl)=C5OC5=C(Cl)C(=O)C(Cl)=CC54)C(C(O)=O)=C(Cl)C=3)Cl)N=CC=2)=N1 VZJCYHQIJKTKCJ-UHFFFAOYSA-N 0.000 claims 4
- VDVOBHGYLRGHPS-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)-n-(2-thiophen-2-ylethyl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C(=O)NCCC=2SC=CC=2)C=2N=C(N)N=CC=2)=N1 VDVOBHGYLRGHPS-UHFFFAOYSA-N 0.000 claims 4
- YUPNYCFIICXNPO-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)-n-methylsulfonylimidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NS(C)(=O)=O)C=2N=C(N)N=CC=2)=N1 YUPNYCFIICXNPO-UHFFFAOYSA-N 0.000 claims 4
- CLIRYVSLRLIRFS-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=C(C=CC3=N2)C(N)=O)C=2N=C(N)N=CC=2)=N1 CLIRYVSLRLIRFS-UHFFFAOYSA-N 0.000 claims 4
- QNKDCPDOULOXBJ-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-(2-hydroxyethyl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NCCO)C=2N=C(N)N=CC=2)=N1 QNKDCPDOULOXBJ-UHFFFAOYSA-N 0.000 claims 4
- IHBLACKKNNTMNA-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-n-[3-(4-methylpiperazin-1-yl)propyl]-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-6-carboxamide Chemical compound C1CN(C)CCN1CCCNC(=O)C1=CN2C(C=3N=C(N)N=CC=3)=C(C=3N=C(C)C=CC=3)N=C2C=C1 IHBLACKKNNTMNA-UHFFFAOYSA-N 0.000 claims 4
- NKZVQBJACLKGJT-UHFFFAOYSA-N 3-[2-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine Chemical compound C1CN(C)CCN1C1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 NKZVQBJACLKGJT-UHFFFAOYSA-N 0.000 claims 4
- XAZXLZNLGFUKFB-UHFFFAOYSA-N 3-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]phenol Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NC=3C=C(O)C=CC=3)N=CC=2)=N1 XAZXLZNLGFUKFB-UHFFFAOYSA-N 0.000 claims 4
- AGSSPIXIGIFOKP-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)-7-(trifluoromethyl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(F)(F)F)C=2N=C(N)N=CC=2)=N1 AGSSPIXIGIFOKP-UHFFFAOYSA-N 0.000 claims 4
- RMHURWLBIXLSDK-UHFFFAOYSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-(1h-pyrazol-5-yl)pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NC=3NN=CC=3)N=CC=2)=N1 RMHURWLBIXLSDK-UHFFFAOYSA-N 0.000 claims 4
- VHVLKQPXJUKJFV-SFHVURJKSA-N 4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-n-[(1s)-1-phenylethyl]pyrimidin-2-amine Chemical compound N([C@@H](C)C=1C=CC=CC=1)C(N=1)=NC=CC=1C(N1C=CC=CC1=N1)=C1C1=CC=CC(C)=N1 VHVLKQPXJUKJFV-SFHVURJKSA-N 0.000 claims 4
- MYKNCPCNCPKGDH-UHFFFAOYSA-N 4-[2-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]ethyl]benzenesulfonamide Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCC=3C=CC(=CC=3)S(N)(=O)=O)N=CC=2)=N1 MYKNCPCNCPKGDH-UHFFFAOYSA-N 0.000 claims 4
- MSSYFOCCFPTMEM-UHFFFAOYSA-N 4-[4-[2-(6-methylpyridin-2-yl)pyrazolo[1,5-c]pyrimidin-3-yl]pyrimidin-2-yl]morpholine Chemical compound CC1=CC=CC(C=2C(=C3C=CN=CN3N=2)C=2N=C(N=CC=2)N2CCOCC2)=N1 MSSYFOCCFPTMEM-UHFFFAOYSA-N 0.000 claims 4
- DFMXDYMTTUZLHC-UHFFFAOYSA-N 4-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidin-1-yl]sulfonyl-5-methyl-1,2-oxazole Chemical compound O1N=CC(S(=O)(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=C(C)C=CC=2)=C1C DFMXDYMTTUZLHC-UHFFFAOYSA-N 0.000 claims 4
- QVXCQUWCCGYXPM-UHFFFAOYSA-N 4-[7-(aminomethyl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC(CN)=CC3=N2)C=2N=C(N)N=CC=2)=N1 QVXCQUWCCGYXPM-UHFFFAOYSA-N 0.000 claims 4
- HPUFRDPDKQBLDH-UHFFFAOYSA-N 4-propan-2-yloxy-6-(5-pyridin-2-yl-1h-pyrazol-4-yl)quinazoline Chemical compound C1=C2C(OC(C)C)=NC=NC2=CC=C1C1=CNN=C1C1=CC=CC=N1 HPUFRDPDKQBLDH-UHFFFAOYSA-N 0.000 claims 4
- ZLZCRVQDMUKNHC-UHFFFAOYSA-N 5-(dimethylamino)-n-[4-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]butyl]naphthalene-1-sulfonamide Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(=O)(=O)NCCCCNC(N=1)=NC=CC=1C(N1C=CC=CC1=N1)=C1C1=CC=CC(C)=N1 ZLZCRVQDMUKNHC-UHFFFAOYSA-N 0.000 claims 4
- OREILLURMWYPQE-UHFFFAOYSA-N 6-(5-pyridin-2-yl-1h-pyrazol-4-yl)-4h-1,4-benzoxazin-3-one Chemical compound C1=C2NC(=O)COC2=CC=C1C1=CNN=C1C1=CC=CC=N1 OREILLURMWYPQE-UHFFFAOYSA-N 0.000 claims 4
- COOYKNZJWSGUJD-UHFFFAOYSA-N 6-[5-(2-cyclopropylpyrimidin-4-yl)-2-(1-methylsulfonylpiperidin-4-yl)-1h-imidazol-4-yl]quinoxaline Chemical compound C1CN(S(=O)(=O)C)CCC1C1=NC(C=2C=C3N=CC=NC3=CC=2)=C(C=2N=C(N=CC=2)C2CC2)N1 COOYKNZJWSGUJD-UHFFFAOYSA-N 0.000 claims 4
- PHIYKABHHHBNIA-UHFFFAOYSA-N 6-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]quinoline Chemical compound CC1=CC=CC(C=2C(=CNN=2)C=2C=C3C=CC=NC3=CC=2)=N1 PHIYKABHHHBNIA-UHFFFAOYSA-N 0.000 claims 4
- VXJLYXCHOKEODY-UHFFFAOYSA-N 6-[5-(6-methylpyridin-2-yl)-1h-pyrazol-4-yl]quinoxaline Chemical compound CC1=CC=CC(C=2C(=CNN=2)C=2C=C3N=CC=NC3=CC=2)=N1 VXJLYXCHOKEODY-UHFFFAOYSA-N 0.000 claims 4
- TYUINBRGEGXQGY-UHFFFAOYSA-N 6-[6-methyl-2-(6-methylpyridin-2-yl)-8-(2-pyridin-4-ylethylamino)imidazo[1,2-a]pyridin-3-yl]-1h-pyrimidin-2-one Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(O)N=CC=3)N2C=C(C)C=C1NCCC1=CC=NC=C1 TYUINBRGEGXQGY-UHFFFAOYSA-N 0.000 claims 4
- WHIRSMPBKKWVNL-UHFFFAOYSA-N 6-[8-bromo-6-methyl-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]-1h-pyrimidin-2-one Chemical compound N12C=C(C)C=C(Br)C2=NC(C=2N=C(C)C=CC=2)=C1C1=CC=NC(O)=N1 WHIRSMPBKKWVNL-UHFFFAOYSA-N 0.000 claims 4
- VIRLLLRMQBHWCT-UHFFFAOYSA-N 6-chloro-2-(6-methylpyridin-2-yl)-3-(2-methylsulfonylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CC1=CC=CC(C2=C(N3C=C(Cl)C=CC3=N2)C=2N=C(N=CC=2)S(C)(=O)=O)=N1 VIRLLLRMQBHWCT-UHFFFAOYSA-N 0.000 claims 4
- VQLOYGTZJBJXHP-UHFFFAOYSA-N [1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]-pyrrolidin-1-ylmethanone Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)N2CCCC2)C=2C=C3OCOC3=CC=2)=N1 VQLOYGTZJBJXHP-UHFFFAOYSA-N 0.000 claims 4
- JMDJSUXTQIQLKM-UHFFFAOYSA-N [4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidin-1-yl]-(4-fluorophenyl)methanone Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)C=2C=CC(F)=CC=2)C=2C=C3OCOC3=CC=2)=N1 JMDJSUXTQIQLKM-UHFFFAOYSA-N 0.000 claims 4
- IJHGFKLYZUZFRU-UHFFFAOYSA-N benzyl 4-[4-(1,3-benzodioxol-5-yl)-5-(6-bromopyridin-2-yl)-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound BrC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 IJHGFKLYZUZFRU-UHFFFAOYSA-N 0.000 claims 4
- ITILYPBCIWETKV-UHFFFAOYSA-N benzyl 4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 ITILYPBCIWETKV-UHFFFAOYSA-N 0.000 claims 4
- FTKRHDBAUOEGGQ-UHFFFAOYSA-N benzyl 4-[4-quinoxalin-6-yl-5-[2-(trifluoromethyl)pyrimidin-4-yl]-1h-imidazol-2-yl]piperidine-1-carboxylate Chemical compound FC(F)(F)C1=NC=CC(C2=C(N=C(N2)C2CCN(CC2)C(=O)OCC=2C=CC=CC=2)C=2C=C3N=CC=NC3=CC=2)=N1 FTKRHDBAUOEGGQ-UHFFFAOYSA-N 0.000 claims 4
- 229940098779 methanesulfonic acid Drugs 0.000 claims 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Substances CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 4
- DFMWOFQKSBDAJT-UHFFFAOYSA-N methyl 1-[5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxylate Chemical compound C1CC(C(=O)OC)(CC2)CCC12C(N1)=NC(C2=CN3N=CN=C3C=C2)=C1C1=CC=CC(C)=N1 DFMWOFQKSBDAJT-UHFFFAOYSA-N 0.000 claims 4
- OYNAFVDEMSUPFN-UHFFFAOYSA-N n'-[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]butane-1,4-diamine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCCN)N=CC=2)=N1 OYNAFVDEMSUPFN-UHFFFAOYSA-N 0.000 claims 4
- OXHZBUYAJNKADR-UHFFFAOYSA-N n'-[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]propane-1,3-diamine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCN)N=CC=2)=N1 OXHZBUYAJNKADR-UHFFFAOYSA-N 0.000 claims 4
- VKJINYHQKFWPDV-UHFFFAOYSA-N n-(2-aminoethyl)-3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridine-7-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(=CC3=N2)C(=O)NCCN)C=2N=C(N)N=CC=2)=N1 VKJINYHQKFWPDV-UHFFFAOYSA-N 0.000 claims 4
- DPYZUMFTTWFGPP-UHFFFAOYSA-N n-(benzenesulfonyl)-1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NS(=O)(=O)C=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 DPYZUMFTTWFGPP-UHFFFAOYSA-N 0.000 claims 4
- CERYWFBSRQOQIA-UHFFFAOYSA-N n-[(4-methoxyphenyl)methyl]-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound C1=CC(OC)=CC=C1CNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 CERYWFBSRQOQIA-UHFFFAOYSA-N 0.000 claims 4
- RBFATPKRZTTYKI-UHFFFAOYSA-N n-[1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]-2,2,2-trifluoroacetamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)NC(=O)C(F)(F)F)C=2C=C3OCOC3=CC=2)=N1 RBFATPKRZTTYKI-UHFFFAOYSA-N 0.000 claims 4
- ORDRWSKGQYJUQB-UHFFFAOYSA-N n-[1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]-2,2,2-trifluoroacetamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)NC(=O)C(F)(F)F)C=2N=C(NC3CC3)N=CC=2)=N1 ORDRWSKGQYJUQB-UHFFFAOYSA-N 0.000 claims 4
- OSXUPRKKVSLTEZ-UHFFFAOYSA-N n-[1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]acetamide Chemical compound C1CC(NC(=O)C)(CC2)CCC12C(N1)=NC(C=2N=C(C)C=CC=2)=C1C(N=1)=CC=NC=1NC1CC1 OSXUPRKKVSLTEZ-UHFFFAOYSA-N 0.000 claims 4
- BDQSLLQVJGTDGH-UHFFFAOYSA-N n-[1-[5-[2-(cyclopropylamino)pyrimidin-4-yl]-4-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-4-bicyclo[2.2.2]octanyl]methanesulfonamide Chemical compound CC1=CC=CC(C2=C(NC(=N2)C23CCC(CC2)(CC3)NS(C)(=O)=O)C=2N=C(NC3CC3)N=CC=2)=N1 BDQSLLQVJGTDGH-UHFFFAOYSA-N 0.000 claims 4
- VXYQMZJVBIOSHZ-UHFFFAOYSA-N n-[2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyrimidin-7-yl]pyridine-3-carboxamide Chemical compound CSC1=NC=CC(C=2N3C=CC(NC(=O)C=4C=NC=CC=4)=NC3=NC=2C=2N=C(C)C=CC=2)=N1 VXYQMZJVBIOSHZ-UHFFFAOYSA-N 0.000 claims 4
- LNJWCRITIZFPCK-UHFFFAOYSA-N n-[2-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]ethyl]acetamide Chemical compound CC(=O)NCCNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 LNJWCRITIZFPCK-UHFFFAOYSA-N 0.000 claims 4
- QCWUMXGINRGKHD-UHFFFAOYSA-N n-[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidin-7-yl]-3,3-dimethylbutanamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(NC(=O)CC(C)(C)C)=NC3=N2)C=2N=C(N)N=CC=2)=N1 QCWUMXGINRGKHD-UHFFFAOYSA-N 0.000 claims 4
- UYQAOMNHPUTELT-UHFFFAOYSA-N n-[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidin-7-yl]-3-pyridin-3-ylpropanamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(NC(=O)CCC=4C=NC=CC=4)=NC3=N2)C=2N=C(N)N=CC=2)=N1 UYQAOMNHPUTELT-UHFFFAOYSA-N 0.000 claims 4
- RYFGJBIOMCAFFZ-UHFFFAOYSA-N n-[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidin-7-yl]propanamide Chemical compound N1=C2N=C(NC(=O)CC)C=CN2C(C=2N=C(N)N=CC=2)=C1C1=CC=CC(C)=N1 RYFGJBIOMCAFFZ-UHFFFAOYSA-N 0.000 claims 4
- XCFCMXMGTBEOGF-UHFFFAOYSA-N n-[3-(2-aminopyrimidin-4-yl)-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyrimidin-7-yl]pyridine-3-carboxamide Chemical compound CC1=CC=CC(C2=C(N3C=CC(NC(=O)C=4C=NC=CC=4)=NC3=N2)C=2N=C(N)N=CC=2)=N1 XCFCMXMGTBEOGF-UHFFFAOYSA-N 0.000 claims 4
- GATOOMWOKQPQIA-UHFFFAOYSA-N n-[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]cyclohexyl]-1-pyridin-2-ylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCC(CC2)NS(=O)(=O)CC=2N=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 GATOOMWOKQPQIA-UHFFFAOYSA-N 0.000 claims 4
- WDETXUVGXDZSND-UHFFFAOYSA-N n-[4-[5-(6-methylpyridin-2-yl)-4-quinoxalin-6-yl-1h-imidazol-2-yl]cyclohexyl]acetamide Chemical compound C1CC(NC(=O)C)CCC1C1=NC(C=2N=C(C)C=CC=2)=C(C=2C=C3N=CC=NC3=CC=2)N1 WDETXUVGXDZSND-UHFFFAOYSA-N 0.000 claims 4
- BCXKGIAQNYLJGM-UHFFFAOYSA-N n-[4-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]butyl]acetamide Chemical compound CC(=O)NCCCCNC1=NC=CC(C=2N3C=CC=CC3=NC=2C=2N=C(C)C=CC=2)=N1 BCXKGIAQNYLJGM-UHFFFAOYSA-N 0.000 claims 4
- AYSAZHWWLDKAHP-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]methyl]-1-pyridin-2-ylmethanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CNS(=O)(=O)CC=4N=CC=CC=4)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 AYSAZHWWLDKAHP-UHFFFAOYSA-N 0.000 claims 4
- OVOVWHQXIRPYJB-UHFFFAOYSA-N n-[[4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-1-bicyclo[2.2.2]octanyl]methyl]methanesulfonamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CNS(C)(=O)=O)(CC2)CC3)C=2C=C3OCOC3=CC=2)=N1 OVOVWHQXIRPYJB-UHFFFAOYSA-N 0.000 claims 4
- ZBEAWGUBZOQONV-UHFFFAOYSA-N n-cyclopentyl-5-(5-pyridin-2-yl-1h-pyrazol-4-yl)-1h-indazole-3-carboxamide Chemical compound N=1NC2=CC=C(C=3C(=NNC=3)C=3N=CC=CC=3)C=C2C=1C(=O)NC1CCCC1 ZBEAWGUBZOQONV-UHFFFAOYSA-N 0.000 claims 4
- BAFUGFTZYCDGRM-UHFFFAOYSA-N n-cyclopropyl-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NC3CC3)N=CC=2)=N1 BAFUGFTZYCDGRM-UHFFFAOYSA-N 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- XPYZSOJKFJRHIS-UHFFFAOYSA-N tert-butyl n-[3-[[4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-yl]amino]propyl]carbamate Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NCCCNC(=O)OC(C)(C)C)N=CC=2)=N1 XPYZSOJKFJRHIS-UHFFFAOYSA-N 0.000 claims 4
- WBYIDWODCBKPKM-UHFFFAOYSA-N 2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)pyrazolo[1,5-a]pyridine Chemical compound CSC1=NC=CC(C2=C3C=CC=CN3N=C2C=2N=C(C)C=CC=2)=N1 WBYIDWODCBKPKM-UHFFFAOYSA-N 0.000 claims 3
- PBQVYGAFMWMPQG-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-(1-methylsulfonylpiperidin-4-yl)-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(C)(=O)=O)C=2C=C3OCOC3=CC=2)=N1 PBQVYGAFMWMPQG-UHFFFAOYSA-N 0.000 claims 3
- CVEXHODKIZBOMC-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(3,5-difluorophenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=C(F)C=C(F)C=2)C=2C=C3OCOC3=CC=2)=N1 CVEXHODKIZBOMC-UHFFFAOYSA-N 0.000 claims 3
- LRAVQICQOUSVKQ-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[(3-phenoxyphenyl)methylsulfonyl]piperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound CC1=CC=CC(C2=C(N=C(N2)C2CCN(CC2)S(=O)(=O)CC=2C=C(OC=3C=CC=CC=3)C=CC=2)C=2C=C3OCOC3=CC=2)=N1 LRAVQICQOUSVKQ-UHFFFAOYSA-N 0.000 claims 3
- CTYCYBCAYNIGGD-UHFFFAOYSA-N 2-[4-(1,3-benzodioxol-5-yl)-2-[1-[5-methyl-2-(trifluoromethyl)furan-3-yl]sulfonylpiperidin-4-yl]-1h-imidazol-5-yl]-6-methylpyridine Chemical compound O1C(C)=CC(S(=O)(=O)N2CCC(CC2)C=2NC(=C(N=2)C=2C=C3OCOC3=CC=2)C=2N=C(C)C=CC=2)=C1C(F)(F)F CTYCYBCAYNIGGD-UHFFFAOYSA-N 0.000 claims 3
- GNCJJLAGVLNJOB-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-6-methyl-2-(6-methylpyridin-2-yl)-n-(2-pyridin-2-ylethyl)imidazo[1,2-a]pyridin-8-amine Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(N)N=CC=3)N2C=C(C)C=C1NCCC1=CC=CC=N1 GNCJJLAGVLNJOB-UHFFFAOYSA-N 0.000 claims 3
- HMBBFJLPVIOKEQ-UHFFFAOYSA-N 3-(2-aminopyrimidin-4-yl)-6-methyl-2-(6-methylpyridin-2-yl)-n-(3-morpholin-4-ylpropyl)imidazo[1,2-a]pyridin-8-amine Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(N)N=CC=3)N2C=C(C)C=C1NCCCN1CCOCC1 HMBBFJLPVIOKEQ-UHFFFAOYSA-N 0.000 claims 3
- HQTYIMWMJZWTMU-UHFFFAOYSA-N 4-[2-(1-butylsulfonylpiperidin-4-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-4-yl]-n-[(4-methoxyphenyl)methyl]pyridin-2-amine Chemical compound C1CN(S(=O)(=O)CCCC)CCC1C1=NC(C=2C=C(NCC=3C=CC(OC)=CC=3)N=CC=2)=C(C=2N=C(C)C=CC=2)N1 HQTYIMWMJZWTMU-UHFFFAOYSA-N 0.000 claims 3
- GKODTPGEVLRHGQ-UHFFFAOYSA-N 4-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]bicyclo[2.2.2]octane-1-carbonitrile Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C#N)C=2C=C3OCOC3=CC=2)=N1 GKODTPGEVLRHGQ-UHFFFAOYSA-N 0.000 claims 3
- BBOXUBICUADAOW-UHFFFAOYSA-N 4-[6-bromo-2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=C(Br)C=CC3=N2)C=2N=C(N)N=CC=2)=N1 BBOXUBICUADAOW-UHFFFAOYSA-N 0.000 claims 3
- ZERZJCFHVWAURI-UHFFFAOYSA-N 6-[6-methyl-2-(6-methylpyridin-2-yl)-8-(2-pyridin-3-ylethylamino)imidazo[1,2-a]pyridin-3-yl]-1h-pyrimidin-2-one Chemical compound C12=NC(C=3N=C(C)C=CC=3)=C(C=3N=C(O)N=CC=3)N2C=C(C)C=C1NCCC1=CC=CN=C1 ZERZJCFHVWAURI-UHFFFAOYSA-N 0.000 claims 3
- NPPIDUZDOYJWOV-UHFFFAOYSA-N benzyl n-[4-[4-(1,3-benzodioxol-5-yl)-3-(6-methylpyridin-2-yl)pyrazol-1-yl]cyclohexyl]carbamate Chemical compound CC1=CC=CC(C=2C(=CN(N=2)C2CCC(CC2)NC(=O)OCC=2C=CC=CC=2)C=2C=C3OCOC3=CC=2)=N1 NPPIDUZDOYJWOV-UHFFFAOYSA-N 0.000 claims 3
- GAXOXEQTVABLDL-UHFFFAOYSA-N n-cyclobutyl-4-[2-(6-methylpyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]pyrimidin-2-amine Chemical compound CC1=CC=CC(C2=C(N3C=CC=CC3=N2)C=2N=C(NC3CCC3)N=CC=2)=N1 GAXOXEQTVABLDL-UHFFFAOYSA-N 0.000 claims 3
- KKVJMMSITMLWCO-UHFFFAOYSA-N 1-[4-(1,3-benzodioxol-5-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]-n-(furan-2-ylmethyl)bicyclo[2.2.2]octane-4-carboxamide Chemical compound CC1=CC=CC(C2=C(N=C(N2)C23CCC(CC2)(CC3)C(=O)NCC=2OC=CC=2)C=2C=C3OCOC3=CC=2)=N1 KKVJMMSITMLWCO-UHFFFAOYSA-N 0.000 claims 2
- ZTXZDMPLXAIHOB-UHFFFAOYSA-N 6-fluoro-2-(6-methylpyridin-2-yl)-3-(2-methylsulfanylpyrimidin-4-yl)imidazo[1,2-a]pyridine Chemical compound CSC1=NC=CC(C=2N3C=C(F)C=CC3=NC=2C=2N=C(C)C=CC=2)=N1 ZTXZDMPLXAIHOB-UHFFFAOYSA-N 0.000 claims 2
- 125000005605 benzo group Chemical group 0.000 claims 2
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 claims 2
- HNDXKIMMSFCCFW-UHFFFAOYSA-N propane-2-sulphonic acid Chemical compound CC(C)S(O)(=O)=O HNDXKIMMSFCCFW-UHFFFAOYSA-N 0.000 claims 2
- PREOONMJIVUPMI-UHFFFAOYSA-N 1,4-dioxan-2-ylmethanamine Chemical compound NCC1COCCO1 PREOONMJIVUPMI-UHFFFAOYSA-N 0.000 claims 1
- QDHFHIQKOVNCNC-UHFFFAOYSA-N butane-1-sulfonic acid Chemical compound CCCCS(O)(=O)=O QDHFHIQKOVNCNC-UHFFFAOYSA-N 0.000 claims 1
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 claims 1
- DDRPCXLAQZKBJP-UHFFFAOYSA-N furfurylamine Chemical compound NCC1=CC=CO1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 230000000747 cardiac effect Effects 0.000 abstract description 7
- 230000008816 organ damage Effects 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 3
- 102000009618 Transforming Growth Factors Human genes 0.000 description 46
- 108010009583 Transforming Growth Factors Proteins 0.000 description 46
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- 108010059616 Activins Proteins 0.000 description 19
- 102000005606 Activins Human genes 0.000 description 19
- 239000000488 activin Substances 0.000 description 19
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 17
- 239000000543 intermediate Substances 0.000 description 17
- 108020003175 receptors Proteins 0.000 description 17
- 102000005962 receptors Human genes 0.000 description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 125000001424 substituent group Chemical group 0.000 description 13
- LNJMHEJAYSYZKK-UHFFFAOYSA-N 2-methylpyrimidine Chemical class CC1=NC=CC=N1 LNJMHEJAYSYZKK-UHFFFAOYSA-N 0.000 description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 11
- 230000001684 chronic effect Effects 0.000 description 11
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 10
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 10
- 239000005557 antagonist Substances 0.000 description 10
- 210000000651 myofibroblast Anatomy 0.000 description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 8
- 150000001299 aldehydes Chemical class 0.000 description 7
- 125000004181 carboxyalkyl group Chemical group 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 125000003226 pyrazolyl group Chemical group 0.000 description 7
- 125000000714 pyrimidinyl group Chemical group 0.000 description 7
- 125000003396 thiol group Chemical class [H]S* 0.000 description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 7
- NWGPLYYBECWONP-UHFFFAOYSA-N (carbamoylamino) hydrogen sulfate Chemical compound NC(=O)NOS(O)(=O)=O NWGPLYYBECWONP-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 6
- 239000007821 HATU Substances 0.000 description 6
- 210000002744 extracellular matrix Anatomy 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 230000002792 vascular Effects 0.000 description 6
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 5
- 229910004373 HOAc Inorganic materials 0.000 description 5
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 5
- 229910010062 TiCl3 Inorganic materials 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 125000005842 heteroatom Chemical group 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000002685 pulmonary effect Effects 0.000 description 5
- 125000006413 ring segment Chemical group 0.000 description 5
- 238000006467 substitution reaction Methods 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 5
- 210000005166 vasculature Anatomy 0.000 description 5
- UBWXUGDQUBIEIZ-UHFFFAOYSA-N (13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl) 3-phenylpropanoate Chemical compound CC12CCC(C3CCC(=O)C=C3CC3)C3C1CCC2OC(=O)CCC1=CC=CC=C1 UBWXUGDQUBIEIZ-UHFFFAOYSA-N 0.000 description 4
- 206010063209 Chronic allograft nephropathy Diseases 0.000 description 4
- 201000001200 Crouzon syndrome-acanthosis nigricans syndrome Diseases 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N acetaldehyde dimethyl acetal Natural products COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 230000003176 fibrotic effect Effects 0.000 description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
- 230000026030 halogenation Effects 0.000 description 4
- 238000005658 halogenation reaction Methods 0.000 description 4
- 230000001631 hypertensive effect Effects 0.000 description 4
- 230000007170 pathology Effects 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000010189 synthetic method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 229910001868 water Inorganic materials 0.000 description 4
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- VNHBYKHXBCYPBJ-UHFFFAOYSA-N 5-ethynylimidazo[1,2-a]pyridine Chemical compound C#CC1=CC=CC2=NC=CN12 VNHBYKHXBCYPBJ-UHFFFAOYSA-N 0.000 description 3
- 229930105110 Cyclosporin A Natural products 0.000 description 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 3
- 108010036949 Cyclosporine Proteins 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 102400000401 Latency-associated peptide Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 3
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 3
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 3
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000031481 Pathologic Constriction Diseases 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 238000002399 angioplasty Methods 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- KUMNEOGIHFCNQW-UHFFFAOYSA-N diphenyl phosphite Chemical compound C=1C=CC=CC=1OP([O-])OC1=CC=CC=C1 KUMNEOGIHFCNQW-UHFFFAOYSA-N 0.000 description 3
- 210000004969 inflammatory cell Anatomy 0.000 description 3
- 230000028709 inflammatory response Effects 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 3
- 208000037804 stenosis Diseases 0.000 description 3
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 3
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 3
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Natural products C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 3
- YKPQUSLRUFLVDA-UHFFFAOYSA-N $l^{2}-azanylmethane Chemical compound [NH]C YKPQUSLRUFLVDA-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 125000004608 5,6,7,8-tetrahydroquinolinyl group Chemical group N1=C(C=CC=2CCCCC12)* 0.000 description 2
- 108010005853 Anti-Mullerian Hormone Proteins 0.000 description 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 2
- 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 108010029485 Protein Isoforms Proteins 0.000 description 2
- 102000001708 Protein Isoforms Human genes 0.000 description 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 206010039710 Scleroderma Diseases 0.000 description 2
- 229910010061 TiC13 Inorganic materials 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 108010023082 activin A Proteins 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 2
- 239000000868 anti-mullerian hormone Substances 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 229940112869 bone morphogenetic protein Drugs 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000006274 endogenous ligand Substances 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000012744 immunostaining Methods 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 125000002346 iodo group Chemical group I* 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 2
- UGVPKMAWLOMPRS-UHFFFAOYSA-M magnesium;propane;bromide Chemical compound [Mg+2].[Br-].CC[CH2-] UGVPKMAWLOMPRS-UHFFFAOYSA-M 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 208000030613 peripheral artery disease Diseases 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000007634 remodeling Methods 0.000 description 2
- 230000008458 response to injury Effects 0.000 description 2
- 208000037812 secondary pulmonary hypertension Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- YUXKOWPNKJSTPQ-AXWWPMSFSA-N (2s,3r)-2-amino-3-hydroxybutanoic acid;(2s)-2-amino-3-hydroxypropanoic acid Chemical compound OC[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O YUXKOWPNKJSTPQ-AXWWPMSFSA-N 0.000 description 1
- LQAUXDMGRBWDIU-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)methanamine Chemical compound NCC1=CC=C(F)C(Cl)=C1 LQAUXDMGRBWDIU-UHFFFAOYSA-N 0.000 description 1
- CUKWUWBLQQDQAC-VEQWQPCFSA-N (3s)-3-amino-4-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s,3s)-1-[[(2s)-1-[(2s)-2-[[(1s)-1-carboxyethyl]carbamoyl]pyrrolidin-1-yl]-3-(1h-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-ox Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 CUKWUWBLQQDQAC-VEQWQPCFSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
- ULVSHNOGEVXRDR-UHFFFAOYSA-N 1,1-dimethoxypropan-2-one Chemical compound COC(OC)C(C)=O ULVSHNOGEVXRDR-UHFFFAOYSA-N 0.000 description 1
- LDZGWHKUCWHNNP-UHFFFAOYSA-N 1,2-di(pyrimidin-2-yl)ethane-1,2-dione Chemical compound N=1C=CC=NC=1C(=O)C(=O)C1=NC=CC=N1 LDZGWHKUCWHNNP-UHFFFAOYSA-N 0.000 description 1
- FTNJQNQLEGKTGD-UHFFFAOYSA-N 1,3-benzodioxole Chemical compound C1=CC=C2OCOC2=C1 FTNJQNQLEGKTGD-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- BWIHJLOBZMKPKS-UHFFFAOYSA-N 2-(1h-pyrazol-5-yl)pyrimidine Chemical compound N1C=CC(C=2N=CC=CN=2)=N1 BWIHJLOBZMKPKS-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006040 2-hexenyl group Chemical group 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- KDHWOCLBMVSZPG-UHFFFAOYSA-N 3-imidazol-1-ylpropan-1-amine Chemical compound NCCCN1C=CN=C1 KDHWOCLBMVSZPG-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 1
- XEKAWZARUWARND-UHFFFAOYSA-N 6h-oxazin-3-one Chemical compound O=C1NOCC=C1 XEKAWZARUWARND-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- OQLZINXFSUDMHM-UHFFFAOYSA-N Acetamidine Chemical class CC(N)=N OQLZINXFSUDMHM-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- 102400000345 Angiotensin-2 Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 206010003226 Arteriovenous fistula Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 101100355609 Caenorhabditis elegans rae-1 gene Proteins 0.000 description 1
- 208000014882 Carotid artery disease Diseases 0.000 description 1
- 241001432959 Chernes Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 208000004248 Familial Primary Pulmonary Hypertension Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 108010004250 Inhibins Proteins 0.000 description 1
- 102000002746 Inhibins Human genes 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- 101800001155 Latency-associated peptide Proteins 0.000 description 1
- 229910013470 LiC1 Inorganic materials 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 150000004259 N,P-acetals Chemical class 0.000 description 1
- 229910017852 NH2NH2 Inorganic materials 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 108010009341 Protein Serine-Threonine Kinases Proteins 0.000 description 1
- 102000009516 Protein Serine-Threonine Kinases Human genes 0.000 description 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 101100437153 Rattus norvegicus Acvr2b gene Proteins 0.000 description 1
- 108091005682 Receptor kinases Proteins 0.000 description 1
- 206010038366 Renal aneurysm Diseases 0.000 description 1
- 206010039163 Right ventricular failure Diseases 0.000 description 1
- 229910006069 SO3H Inorganic materials 0.000 description 1
- 101150055528 SPAM1 gene Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 102000007614 Thrombospondin 1 Human genes 0.000 description 1
- 108010046722 Thrombospondin 1 Proteins 0.000 description 1
- 206010060872 Transplant failure Diseases 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 150000001409 amidines Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000003433 aortic smooth muscle cell Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 150000001502 aryl halides Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- GPRLTFBKWDERLU-UHFFFAOYSA-N bicyclo[2.2.2]octane Chemical compound C1CC2CCC1CC2 GPRLTFBKWDERLU-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 125000005620 boronic acid group Chemical group 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000006041 cell recruitment Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 208000018631 connective tissue disease Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 125000004966 cyanoalkyl group Chemical group 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 125000004856 decahydroquinolinyl group Chemical group N1(CCCC2CCCCC12)* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000012351 deprotecting agent Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 125000005879 dioxolanyl group Chemical group 0.000 description 1
- 230000007783 downstream signaling Effects 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000004967 formylalkyl group Chemical group 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- LPAGFVYQRIESJQ-UHFFFAOYSA-N indoline Chemical compound C1=CC=C2NCCC2=C1 LPAGFVYQRIESJQ-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000000893 inhibin Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002608 intravascular ultrasound Methods 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 208000037906 ischaemic injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000009681 mesenchymal cell proliferation Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- KRKPYFLIYNGWTE-UHFFFAOYSA-N n,o-dimethylhydroxylamine Chemical compound CNOC KRKPYFLIYNGWTE-UHFFFAOYSA-N 0.000 description 1
- MUSIZCPSZCPDMO-UHFFFAOYSA-N n-butylnonanamide Chemical compound CCCCCCCCC(=O)NCCCC MUSIZCPSZCPDMO-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000004897 n-terminal region Anatomy 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000008692 neointimal formation Effects 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- 125000005889 octahydrochromenyl group Chemical group 0.000 description 1
- 125000005060 octahydroindolyl group Chemical group N1(CCC2CCCCC12)* 0.000 description 1
- 229940046781 other immunosuppressants in atc Drugs 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 201000008312 primary pulmonary hypertension Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- CCOXWRVWKFVFDG-UHFFFAOYSA-N pyrimidine-2-carbaldehyde Chemical class O=CC1=NC=CC=N1 CCOXWRVWKFVFDG-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000011808 rodent model Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- LENLQGBLVGGAMF-UHFFFAOYSA-N tributyl([1,2,4]triazolo[1,5-a]pyridin-6-yl)stannane Chemical compound C1=C([Sn](CCCC)(CCCC)CCCC)C=CC2=NC=NN21 LENLQGBLVGGAMF-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61911604P | 2004-10-15 | 2004-10-15 | |
US60/619,116 | 2004-10-15 | ||
PCT/US2005/036770 WO2006044509A2 (fr) | 2004-10-15 | 2005-10-13 | Procede pour traiter des lesions vasculaires |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2584248A1 true CA2584248A1 (fr) | 2006-04-27 |
Family
ID=36203501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002584248A Abandoned CA2584248A1 (fr) | 2004-10-15 | 2005-10-13 | Procede pour traiter des lesions vasculaires |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1804801A2 (fr) |
JP (1) | JP2008516962A (fr) |
AR (1) | AR051587A1 (fr) |
AU (1) | AU2005295734A1 (fr) |
CA (1) | CA2584248A1 (fr) |
WO (1) | WO2006044509A2 (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
US8673929B2 (en) * | 2006-07-20 | 2014-03-18 | Gilead Sciences, Inc. | 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
PL2049502T3 (pl) * | 2006-07-28 | 2012-06-29 | Novartis Ag | 2,4-Podstawione chinazoliny jako inhibitory kinazy lipidowej |
WO2008027812A2 (fr) | 2006-08-28 | 2008-03-06 | Forest Laboratories Holdings Limited | Dérivés d'imidazopyridine et d'imidazopyrimidine |
SI3034075T1 (sl) | 2006-11-22 | 2018-12-31 | Incyte Holdings Corporation | Imidazotriazini in imidazopirimidini kot inhibitorji kinaze |
US8138168B1 (en) | 2007-09-26 | 2012-03-20 | Takeda Pharmaceutical Company Limited | Renin inhibitors |
PE20091383A1 (es) * | 2007-10-17 | 2009-10-17 | Novartis Ag | DERIVADOS DE IMIDAZO-[1,2-a]PIRIDINA COMO INHIBIDORES DE ALK-5 Y ALK-4 |
US8349870B2 (en) * | 2008-01-25 | 2013-01-08 | E I Du Pont De Nemours And Company | Fungicidal hetercyclic compounds |
US8865732B2 (en) | 2008-03-21 | 2014-10-21 | Novartis Ag | Heterocyclic compounds and uses thereof |
CL2009000904A1 (es) * | 2008-04-21 | 2010-04-30 | Shionogi & Co | Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende. |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
EP2303881A2 (fr) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Composés inhibiteurs hétérocycliques condensés d'histone déacétylase et/ou de kinases cycline-dépendantes |
JP5640005B2 (ja) | 2008-07-14 | 2014-12-10 | ギリアード サイエンシーズ, インコーポレイテッド | Hdacおよび/またはcdk阻害剤としてのイミダゾシルピリジン化合物 |
US8344018B2 (en) | 2008-07-14 | 2013-01-01 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
NZ590747A (en) | 2008-07-28 | 2012-11-30 | Gilead Sciences Inc | Cycloalkylidene and heterocycloalkylidene hdac inhibitor compounds |
WO2010080357A1 (fr) * | 2008-12-18 | 2010-07-15 | Boehringer Ingelheim International Gmbh | Inhibiteurs du récepteur 5-ht2b de la sérotonine |
PT2432767E (pt) * | 2009-05-19 | 2013-07-25 | Dow Agrosciences Llc | Compostos e métodos para controlo de fungos |
US8258316B2 (en) | 2009-06-08 | 2012-09-04 | Gilead Sciences, Inc. | Alkanoylamino benzamide aniline HDAC inhibitor compounds |
AU2010259042A1 (en) | 2009-06-08 | 2011-12-15 | Gilead Sciences, Inc. | Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds |
KR101774035B1 (ko) | 2009-10-30 | 2017-09-01 | 얀센 파마슈티카 엔.브이. | 이미다조[1,2―b]피리다진 유도체 및 PDE10 저해제로서의 그의 용도 |
US8703760B2 (en) | 2009-12-18 | 2014-04-22 | Mitsubishi Tanabe Pharma Corporation | Antiplatelet agent |
AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
EP2402344A1 (fr) * | 2010-06-29 | 2012-01-04 | Basf Se | Dérivés de pyrazole bicycliques condensés |
JP5959330B2 (ja) * | 2011-06-17 | 2016-08-02 | 田辺三菱製薬株式会社 | 新規抗血小板薬 |
CN103619846B (zh) | 2011-06-27 | 2016-08-17 | 詹森药业有限公司 | 1-芳基-4-甲基-[1,2,4]三唑[4,3-a]喹喔啉衍生物 |
US8889730B2 (en) | 2012-04-10 | 2014-11-18 | Pfizer Inc. | Indole and indazole compounds that activate AMPK |
RU2014149684A (ru) | 2012-05-31 | 2016-07-20 | Ф. Хоффманн-Ля Рош Аг | Производные аминохиназолина и пиридопиримидина |
CN104411312B (zh) | 2012-06-26 | 2018-03-06 | 詹森药业有限公司 | 包括pde2抑制剂例如1‑芳基‑4‑甲基‑[1,2,4]三唑[4,3‑a]‑喹喔啉化合物和pde10抑制剂的用于在治疗神经病学障碍或代谢障碍中使用的组合 |
ES2607184T3 (es) | 2012-07-09 | 2017-03-29 | Janssen Pharmaceutica, N.V. | Inhibidores de la enzima fosfodiesterasa 10 |
MX363461B (es) * | 2012-07-26 | 2019-03-25 | Hoffmann La Roche | Derivados de benzisoxazol como moduladores de la neurogénesis y el uso de los mismos en el tratamiento de enfermedades neurológicas y trastornos neuropsiquiátricos. |
CN105164124B (zh) | 2012-11-19 | 2017-03-15 | 诺华股份有限公司 | 用于治疗寄生虫疾病的化合物和组合物 |
US9242969B2 (en) | 2013-03-14 | 2016-01-26 | Novartis Ag | Biaryl amide compounds as kinase inhibitors |
EP2970177A1 (fr) | 2013-03-15 | 2016-01-20 | Pfizer Inc. | Composés indoliques activant l'ampk |
JP6767875B2 (ja) * | 2014-04-08 | 2020-10-14 | ライジェル ファーマシューティカルズ, インコーポレイテッド | Tgf−ベータ阻害剤としての2,3−二置換ピリジン化合物および使用方法 |
UY36294A (es) | 2014-09-12 | 2016-04-29 | Novartis Ag | Compuestos y composiciones como inhibidores de quinasa |
BR112019005046A2 (pt) | 2016-09-19 | 2019-06-18 | Novartis Ag | combinações terapêuticas compreendendo um inibidor de raf e um inibidor de erk |
US10954216B2 (en) | 2016-12-27 | 2021-03-23 | Riken | BMP-signal-inhibiting compound |
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN114105958B (zh) * | 2021-12-03 | 2022-11-22 | 郑州大学第一附属医院 | 一组含羟肟酸的2-苯氨基嘧啶类衍生物及其应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR039241A1 (es) * | 2002-04-04 | 2005-02-16 | Biogen Inc | Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos |
UA80295C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Pyrazolopyridines and using the same |
UA80296C2 (en) * | 2002-09-06 | 2007-09-10 | Biogen Inc | Imidazolopyridines and methods of making and using the same |
AU2003259475A1 (en) * | 2002-09-18 | 2004-04-08 | Pfizer Products Inc. | Pyrazole derivatives as transforming growth factor (TGF) inhibitors |
EP1581222A2 (fr) * | 2003-01-02 | 2005-10-05 | Millennium Pharmaceuticals, Inc. | Compositions et procedes permettant d'inhiber le tgf-$g(b) |
CL2004000234A1 (es) * | 2003-02-12 | 2005-04-15 | Biogen Idec Inc | Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid |
PA8595001A1 (es) * | 2003-03-04 | 2004-09-28 | Pfizer Prod Inc | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf) |
EP1786803A1 (fr) * | 2004-08-31 | 2007-05-23 | Biogen Idec MA, Inc. | Pyrimidinylpyrazoles utilises comme inhibiteurs de tgf-beta |
WO2006026306A1 (fr) * | 2004-08-31 | 2006-03-09 | Biogen Idec Ma Inc. | Pyrimidinylimidazoles utilises comme inhibiteurs de tgf-beta |
-
2005
- 2005-10-13 CA CA002584248A patent/CA2584248A1/fr not_active Abandoned
- 2005-10-13 EP EP05813747A patent/EP1804801A2/fr not_active Withdrawn
- 2005-10-13 JP JP2007536868A patent/JP2008516962A/ja not_active Withdrawn
- 2005-10-13 WO PCT/US2005/036770 patent/WO2006044509A2/fr active Application Filing
- 2005-10-13 AU AU2005295734A patent/AU2005295734A1/en not_active Abandoned
- 2005-10-17 AR ARP050104336A patent/AR051587A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006044509A2 (fr) | 2006-04-27 |
EP1804801A2 (fr) | 2007-07-11 |
JP2008516962A (ja) | 2008-05-22 |
AR051587A1 (es) | 2007-01-24 |
AU2005295734A1 (en) | 2006-04-27 |
WO2006044509A3 (fr) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2584248A1 (fr) | Procede pour traiter des lesions vasculaires | |
US20060264440A1 (en) | Pyrazoles and methods of making and using the same | |
EP3322706B1 (fr) | Composés substitués de pyrazolo[1,5-a]pyridines comme inhibiteurs de la kinase ret | |
CA2841252C (fr) | 2-pyridylimidazoles substitues utilises comme inhibiteurs d'alk5 et/ou d'alk4 | |
EP1678180B1 (fr) | 2h-[1,2,4|triazolo 4,3-a|pyrazines substituees en tant qu'inhibiteurs de la gsk-3 | |
AU2003228446B2 (en) | Tri-substituted heteroaryls and methods of making and using the same | |
US20080171755A1 (en) | Pyrimidinylpyrazoles as Tgf-Beta Inhibitors | |
RU2020112759A (ru) | Гетероциклические соединения в качестве ингибиторов PAD | |
CA2578630A1 (fr) | Pyrimidinylimidazoles utilises comme inhibiteurs de tgf-beta | |
JP2006502164A5 (fr) | ||
US20100056505A1 (en) | Substituted Pyrazalones | |
AU2003268447A1 (en) | Pyrazolopyridines and method of making and using the same | |
US20240217968A1 (en) | Pharmaceutical compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |